Latest / Clinical Deep Dives / PSYCH 145: Obesity

Transcript

PSYCH 145: Obesity · Clinical Deep Dives

0:00
SPEAKER_01: Imagine prescribing a lifesaving medication,
0:02
SPEAKER_01: right, to a young man experiencing his very first psychotic break.
0:08
SPEAKER_01: You stabilize his mind,
0:09
SPEAKER_01: you know,
0:09
SPEAKER_01: you reunite him with his family,
0:11
SPEAKER_01: and you watch those terrifying hallucinations just fade away.
0:14
SPEAKER_00: Yeah, it feels like a profound clinical victory in the moment.
0:17
SPEAKER_01: Exactly.
0:18
SPEAKER_01: But then 12 months later,
0:20
SPEAKER_01: you look at his chart and you realize
0:21
SPEAKER_01: that same life-saving pill has fundamentally rewritten his body's metabolism.
0:28
SPEAKER_01: He's gained 60 pounds,
0:29
SPEAKER_01: he's developed severe dyslipidemia,
0:31
SPEAKER_01: and he is now teetering right on the edge of type 2 diabetes.
0:35
SPEAKER_00: Right, because we patched the dopamine leak in his brain to stop the psychosis,
0:40
SPEAKER_00: but in doing so,
0:40
SPEAKER_00: we accidentally blocked the histamine and serotonin receptors in his hypothalamus.
0:44
SPEAKER_01: Completely flooding his body's hunger signals.
0:46
SPEAKER_00: Yeah.
0:47
SPEAKER_01: So, welcome to another deep dive.
0:49
SPEAKER_01: Whether you are a psychiatry trainee,
0:50
SPEAKER_01: a registrar preparing for rounds,
0:52
SPEAKER_01: a motivated medical student, or,
0:54
SPEAKER_01: you know,
0:54
SPEAKER_01: just a deeply curious clinician looking to sharpen your reasoning,
0:57
SPEAKER_01: we are thrilled to have you here.
0:59
SPEAKER_00: We really are.
1:00
SPEAKER_01: Today, our mission serves as a companion to Chapter 27.4 of Kaplan
1:05
SPEAKER_01: and Satiker's Comprehensive Textbook of Psychiatry.
1:08
SPEAKER_01: And we are focusing entirely on psychosomatic medicine and obesity.
1:12
SPEAKER_00: And we should clarify, we are not just reciting textbook tables at you.
1:15
SPEAKER_01: No, absolutely not.
1:16
SPEAKER_00: Our goal here is to build robust mental models to really clarify
1:20
SPEAKER_00: the underlying biological and psychological mechanisms.
1:23
SPEAKER_00: We want to drastically strengthen your clinical reasoning.
1:26
SPEAKER_01: And to do that effectively,
1:28
SPEAKER_01: we really have to establish our foundational anchor for this discussion.
1:31
SPEAKER_00: Right.
1:31
SPEAKER_00: We must frame the entire field of psychiatry as the study of how the brain,
1:36
SPEAKER_00: the mind and the individual's experience interact with one another.
1:40
SPEAKER_00: And crucially, we have to examine how that highly complex interactive process can go wrong.
1:45
SPEAKER_01: It's all connected.
1:46
SPEAKER_00: It is.
1:47
SPEAKER_00: When we look at obesity through this specific psychiatric lens,
1:50
SPEAKER_00: it ceases to be a simple issue of mechanical weight management.
1:54
SPEAKER_00: It reveals itself as a profound intersection of biology, environment, and human behavior.
2:00
SPEAKER_01: Yet the visible body weight of a patient sitting in your clinic is basically just
2:04
SPEAKER_01: the final outcome of an entirely invisible, sprawling biological system.
2:09
SPEAKER_00: That's a perfect way to put it.
2:11
SPEAKER_01: I actually want to capture that system with a vivid mental image for you.
2:15
SPEAKER_01: Let's imagine Medlock Holmes,
2:16
SPEAKER_01: the great detective,
2:17
SPEAKER_01: stepping through a heavy set of brass doors and entering what we will call
2:21
SPEAKER_01: the great energy exchange.
2:23
SPEAKER_01: I like this.
2:24
SPEAKER_01: Yeah, so it's this immense neo-Victorian metabolic laboratory.
2:28
SPEAKER_01: It is vast.
2:29
SPEAKER_01: It's filled with clanking gears,
2:31
SPEAKER_01: steam valves,
2:32
SPEAKER_01: and this bewildering network of biological,
2:35
SPEAKER_01: psychological, and environmental machinery.
2:38
SPEAKER_00: And every single calorie that enters the human body must pass through this elaborate labyrinth.
2:43
SPEAKER_01: Exactly.
2:43
SPEAKER_01: But as Medlock Holmes first walks into this grand hall,
2:46
SPEAKER_01: he sees a seemingly primitive equation carved in giant letters into
2:50
SPEAKER_01: the stone wall right at the entrance.
2:52
SPEAKER_01: And it reads, energy in is greater than energy out, which leads to weight gain.
2:57
SPEAKER_00: The classic thermodynamic equation.
2:59
SPEAKER_01: Right.
3:00
SPEAKER_01: And I think this is where a lot of trainees
3:01
SPEAKER_01: and honestly even seasoned clinicians initially get stuck.
3:06
SPEAKER_01: If weight gain is truly just a physics equation of basic thermodynamics,
3:10
SPEAKER_01: why on earth does Medlock Holmes need to be a psychiatrist to solve this case?
3:15
SPEAKER_01: I mean, isn't this just biology?
3:17
SPEAKER_00: Well, the answer lies in the difference between observing an outcome
3:21
SPEAKER_00: and understanding its etiology.
3:22
SPEAKER_01: OK, unpack that a bit.
3:24
SPEAKER_00: That simple equation on the wall,
3:25
SPEAKER_00: energy in versus energy out,
3:28
SPEAKER_00: it only describes the physical reality of what is happening.
3:31
SPEAKER_00: It provides absolutely no insight into the mechanisms driving the imbalance.
3:34
SPEAKER_01: It's just the final ledger.
3:36
SPEAKER_00: Right.
3:36
SPEAKER_00: Behind that crude balance sheet are hundreds of intricately interconnected gears.
3:42
SPEAKER_00: We are talking about genetic susceptibility,
3:44
SPEAKER_00: hypothalamic appetite regulating hormones,
3:46
SPEAKER_00: the highly active gut microbiome,
3:48
SPEAKER_00: Deeply entrenched neural reward circuitry,
3:51
SPEAKER_00: the fluctuations of human mood, trauma,
3:54
SPEAKER_01: and the obesogenic environment itself.
3:55
SPEAKER_00: Exactly.
3:56
SPEAKER_00: To treat the patient effectively,
3:58
SPEAKER_00: the clinician must understand the specific gear that is malfunctioning.
4:02
SPEAKER_01: So our core thesis for this deep dive is that obesity is not a failure of willpower.
4:07
SPEAKER_01: It's not a moral failing.
4:09
SPEAKER_01: It's not a lack of discipline.
4:10
SPEAKER_01: Not at all.
4:11
SPEAKER_01: It is a highly complex chronic condition that emerges from the profound mismatch
4:16
SPEAKER_01: between ancient human biology and the modern world.
4:19
SPEAKER_00: Which is why the American Medical Association officially recognized obesity as
4:23
SPEAKER_00: a disease in 2013.
4:25
SPEAKER_00: That was a massive paradigm shift in how we approach treatment and reimbursement.
4:29
SPEAKER_01: Huge shift.
4:30
SPEAKER_01: And if we look at the epidemiological data in our sources,
4:33
SPEAKER_01: specifically from the National Health and Nutrition Examination Survey,
4:36
SPEAKER_01: or NAAS, it shows a staggering global epidemic.
4:40
SPEAKER_00: It really does.
4:41
SPEAKER_01: We are seeing 42.4% of U.S.
4:43
SPEAKER_01: adults meeting the criteria for obesity alongside approximately 18.5%
4:48
SPEAKER_01: of children ages 2 to 19.
4:50
SPEAKER_01: And we know these rates disproportionately impact minority groups,
4:53
SPEAKER_01: including Hispanic and African-American populations.
4:56
SPEAKER_00: And the clinical classification of these populations relies heavily on
4:59
SPEAKER_00: the body mass index or BMI.
5:01
SPEAKER_01: Which is calculated as weight in kilograms divided by height in meters squared.
5:05
SPEAKER_00: Right.
5:06
SPEAKER_00: The clinical ranges are strictly defined.
5:08
SPEAKER_00: So normal is 18.5 to 24.9.
5:12
SPEAKER_00: Overweight is 25 to 29.9.
5:14
SPEAKER_00: Obesity begins at 30.
5:16
SPEAKER_00: And severe obesity is defined as a BMI greater than 40.
5:20
SPEAKER_01: And for pediatric populations...
5:21
SPEAKER_00: In pediatric populations,
5:22
SPEAKER_00: we use age and sex-specific percentiles,
5:25
SPEAKER_00: where above the 95th percentile constitutes an obesity diagnosis.
5:29
SPEAKER_00: But as a clinician, you must recognize the
5:36
SPEAKER_01: I often think of relying solely on BMI as judging the overall financial health of
5:41
SPEAKER_01: a massive corporation solely by looking at its growth revenue.
5:45
SPEAKER_00: That's a great analogy.
5:46
SPEAKER_01: Because you're completely ignoring its staggering debts,
5:48
SPEAKER_01: its operational costs, and its hidden liquid assets.
5:50
SPEAKER_01: It gives you a number,
5:52
SPEAKER_01: but does it actually give you a comprehensive picture of metabolic health?
5:55
SPEAKER_00: It absolutely does not.
5:56
SPEAKER_00: BMI is an imperfect, highly generalized instrument.
5:59
SPEAKER_00: Its primary utility is in broad population-level epidemiological studies.
6:04
SPEAKER_00: In the individual clinic, it possesses significant flaws.
6:07
SPEAKER_01: Like what specifically?
6:08
SPEAKER_00: Well, BMI cannot distinguish metabolically active insulin-sensitive muscle mass
6:13
SPEAKER_00: from pathogenic fat mass.
6:15
SPEAKER_00: It fails to account for bone density, fluid retention, or cardiovascular fitness.
6:20
SPEAKER_01: Right.
6:20
SPEAKER_01: So a professional athlete with immense skeletal muscle hypertrophy will often have a BMI of 32.
6:26
SPEAKER_00: Exactly.
6:27
SPEAKER_00: Categorizing them as obese,
6:28
SPEAKER_00: despite possessing superb metabolic functioning and zero insulin resistance.
6:33
SPEAKER_00: Furthermore, BMI thresholds do not universally apply across all ethnicities.
6:38
SPEAKER_01: Oh, right.
6:39
SPEAKER_01: The sources mentioned Asian populations specifically.
6:41
SPEAKER_00: Yes.
6:42
SPEAKER_00: Many Asian populations experience severe metabolic complications at much lower BMI thresholds.
6:48
SPEAKER_00: This has actually prompted some guidelines to lower the overweight cutoff to 23
6:52
SPEAKER_00: for these specific demographics.
6:54
SPEAKER_01: Which means we cannot just look at the gross revenue.
6:56
SPEAKER_01: We need a better biometric indicator,
6:59
SPEAKER_01: something that actually reflects the pathogenic potential of the tissue.
7:02
SPEAKER_00: That brings us to waist circumference and the concept of visceral adiposity.
7:06
SPEAKER_00: Clinicians are increasingly relying on waist circumference,
7:08
SPEAKER_00: specifically greater than 35 inches for women or greater than 40 inches for men,
7:13
SPEAKER_00: as a superior indicator of metabolic risk.
7:16
SPEAKER_01: Because high waist circumference points directly to visceral fat, right?
7:19
SPEAKER_00: Yes.
7:20
SPEAKER_00: This is the fat stored deeply around the internal organs,
7:23
SPEAKER_00: the liver, the pancreas, the intestines.
7:26
SPEAKER_01: And why is that worse than the fat just under the skin?
7:28
SPEAKER_00: Because unlike subcutaneous fat, which is relatively inert, visceral fat is highly lipolytic.
7:35
SPEAKER_00: It drains directly into the portal vein,
7:37
SPEAKER_00: exposing the liver to high concentrations of free fatty acids.
7:41
SPEAKER_00: It is a massive driver of systemic insulin resistance and cardiovascular disease.
7:46
SPEAKER_01: Okay, so we have measured the problem,
7:48
SPEAKER_01: and we know that visceral fat is the real culprit here in the great energy exchange.
7:53
SPEAKER_01: Now, Medlock Holmes needs to look at the actual gears driving the machinery.
7:57
SPEAKER_00: Right, the etiology.
7:58
SPEAKER_01: Let's delve into the genetics and biology,
8:00
SPEAKER_01: and here's where we encounter the foundational concept of the evolutionary mismatch.
8:05
SPEAKER_01: In 1962, a geneticist named James Neal proposed the Thrifty Genotype Hypothesis.
8:11
SPEAKER_00: Neil's hypothesis completely reframes our understanding of metabolic storage.
8:16
SPEAKER_00: From an evolutionary perspective,
8:17
SPEAKER_00: human beings spent the vast majority of our history in environments defined
8:20
SPEAKER_00: by extreme caloric scarcity and high physical exhaustion.
8:24
SPEAKER_01: Famines, harsh winters, unsuccessful hunts.
8:28
SPEAKER_01: That was the norm.
8:29
SPEAKER_00: Exactly.
8:30
SPEAKER_00: In that environment,
8:31
SPEAKER_00: the ability to rapidly consume excess calories when available
8:34
SPEAKER_00: and efficiently store them as adipose tissue provided a massive selective advantage.
8:39
SPEAKER_00: Natural selection actively favored thrifty genes that coded
8:42
SPEAKER_00: for highly effective rapid energy storage.
8:45
SPEAKER_01: So we are essentially operating on ancient biological software designed for a world
8:51
SPEAKER_01: where we had to hunt mammoths and survive famines.
8:53
SPEAKER_01: But today we are running that exact same software in a modern world filled
8:58
SPEAKER_01: with 24 hour drive throughs and hyper processed foods.
9:00
SPEAKER_00: The mechanism of that mismatch is profound and
9:03
SPEAKER_00: the genetic component dictating how effectively your body runs
9:06
SPEAKER_00: that ancient software is staggering.
9:08
SPEAKER_01: How much of this is actually genetic?
9:10
SPEAKER_00: The literature,
9:11
SPEAKER_00: particularly twin and adoption studies,
9:13
SPEAKER_00: suggests that heritable genetic differences account for anywhere from 55 percent
9:17
SPEAKER_00: to 85 percent of variance in body weight.
9:19
SPEAKER_01: Up to 85 percent.
9:20
SPEAKER_00: Yes.
9:21
SPEAKER_00: Researchers have identified over 600 single gene mutations
9:25
SPEAKER_00: and genomic regions related to obesity.
9:28
SPEAKER_00: For example,
9:29
SPEAKER_00: Mutations in the melanocortin 4 receptor or MC4R gene are
9:34
SPEAKER_00: the most common monogenic cause of severe early onset obesity.
9:39
SPEAKER_00: It directly impairs the brain's ability to process satiety signals.
9:43
SPEAKER_01: That heritability figure is massive.
9:45
SPEAKER_01: It completely dismantles the whole just eat less narrative.
9:48
SPEAKER_01: If a patient feels like their body is actively fighting their attempts
9:51
SPEAKER_01: to lose weight,
9:52
SPEAKER_01: it is because their biology is literally engineered to resist starvation
9:56
SPEAKER_01: at all costs.
9:57
SPEAKER_00: Precisely.
9:58
SPEAKER_01: And the sources point out something counterintuitive about those twin studies.
10:01
SPEAKER_01: The shared family environment like growing up in the same house with
10:04
SPEAKER_01: the same pantry actually has a minimal effect on long-term BMI.
10:08
SPEAKER_00: That's a really important nuance.
10:10
SPEAKER_00: It is the genetics combined with individual non-shared experiences like
10:13
SPEAKER_00: a child's unique peer group or specific psychological stressors that have
10:17
SPEAKER_00: the most significant impact.
10:18
SPEAKER_01: So the biology always asserts itself.
10:20
SPEAKER_00: Yeah.
10:20
SPEAKER_01: But to truly understand the clinical picture,
10:22
SPEAKER_01: we have to look at what is happening at the cellular level within
10:25
SPEAKER_01: the adipose tissue itself.
10:27
SPEAKER_00: Right.
10:27
SPEAKER_00: Because historically, the medical community viewed adipocytes fat cells as inert storage tanks.
10:32
SPEAKER_00: We thought they were just biological Tupperware passively holding excess triglycerides.
10:37
SPEAKER_01: But that's entirely false.
10:38
SPEAKER_00: Entirely false.
10:40
SPEAKER_00: We now understand the concept of adiposopathy or sick fat.
10:44
SPEAKER_00: Enlarged adipocytes in individuals with obesity act
10:47
SPEAKER_00: as highly active pathogenic endocrine organs.
10:50
SPEAKER_01: Wait, if they are endocrine organs, they must be secreting hormones.
10:53
SPEAKER_01: What exactly are these enlarged fat cells sending out into the bloodstream?
10:57
SPEAKER_00: Well, as oetipocytes undergo massive hypertrophy,
11:00
SPEAKER_00: as they expand to store more energy, they often outgrow their local blood supply.
11:04
SPEAKER_00: Okay.
11:04
SPEAKER_00: This induces cellular hypoxia.
11:07
SPEAKER_00: The stressed fat cells begin to undergo apoptosis,
11:10
SPEAKER_00: or cell death,
11:11
SPEAKER_00: which triggers the infiltration of macrophages from the immune system.
11:15
SPEAKER_01: Wow.
11:15
SPEAKER_01: An immune response to fat cells.
11:17
SPEAKER_00: Yes.
11:18
SPEAKER_00: These macrophages,
11:20
SPEAKER_00: along with the stressed adipocytes themselves,
11:22
SPEAKER_00: begin secreting a storm of pro-inflammatory cytokines,
11:25
SPEAKER_00: such as tumor necrosis factor alpha and interleukin-6.
11:29
SPEAKER_00: This chronic,
11:30
SPEAKER_00: low-grade systemic inflammation actively interferes with insulin receptor signaling
11:35
SPEAKER_00: in skeletal muscle and the liver, directly driving insulin resistance.
11:39
SPEAKER_01: That is fascinating.
11:40
SPEAKER_01: The fat cells are literally suffocating,
11:43
SPEAKER_01: which triggers an immune response,
11:44
SPEAKER_01: and that immune response blocks the insulin from doing its job.
11:47
SPEAKER_00: Exactly.
11:48
SPEAKER_01: But what about the hormones that regulate hunger, like leptin?
11:52
SPEAKER_01: If a patient has an enormous amount of fat cells,
11:54
SPEAKER_01: shouldn't they be producing massive amounts of leptin,
11:57
SPEAKER_01: which signals the brain to stop eating?
11:59
SPEAKER_01: Why doesn't the brain get the message?
12:01
SPEAKER_00: A brilliant question, and it goes to the heart of the pathology.
12:04
SPEAKER_00: Leptin is indeed produced by adipose tissue in proportion to fat mass.
12:08
SPEAKER_00: So an individual with severe obesity has incredibly high circulating levels of leptin.
12:13
SPEAKER_01: So the signal is there.
12:15
SPEAKER_00: The signal is there,
12:16
SPEAKER_00: but the systemic inflammation we just discussed,
12:19
SPEAKER_00: particularly elevated C-reactive protein and other inflammatory markers,
12:23
SPEAKER_00: actively impairs the transport of leptin across the blood-brain barrier.
12:28
SPEAKER_00: Furthermore,
12:29
SPEAKER_00: the leptin receptors in the arcuate nucleus of
12:31
SPEAKER_00: the hypothalamus become downregulated due to constant overstimulations.
12:36
SPEAKER_00: The brain is quite literally deaf to the leptin signal.
12:39
SPEAKER_01: It's a horrific biological trap.
12:41
SPEAKER_00: It is.
12:42
SPEAKER_00: The patient has a massive energy surplus stored in their body,
12:45
SPEAKER_00: but their brain perceives a state of absolute starvation,
12:48
SPEAKER_00: driving an intense biological urge to consume more food.
12:52
SPEAKER_01: The brain thinks the body is starving while the body is suffocating under excess energy.
12:56
SPEAKER_00: Yeah.
12:56
SPEAKER_01: And we cannot discuss metabolism without mentioning the emerging star
12:59
SPEAKER_01: of biological research,
13:01
SPEAKER_01: the gut microbiome, the trillions of bacteria living in our gastrointestinal tract.
13:06
SPEAKER_00: Yes, a robust body of evidence now demonstrates that
13:09
SPEAKER_00: the gastrointestinal microbiota directly impacts dietary energy utilization.
13:14
SPEAKER_00: It is not just about digestion.
13:16
SPEAKER_00: It is about energy harvesting.
13:17
SPEAKER_01: How does that work?
13:18
SPEAKER_00: The microbiome of a patient with obesity often features a distinct compositional shift.
13:24
SPEAKER_00: Historically,
13:24
SPEAKER_00: this is noted as an increased ratio of firmicutes to bacteroidetes,
13:28
SPEAKER_00: though the nuance is evolving.
13:31
SPEAKER_00: These specific microbes are incredibly efficient at fermenting complex,
13:35
SPEAKER_00: indigestible dietary polysaccharides into short-chain fatty acids,
13:40
SPEAKER_00: like butyrate and acetate.
13:41
SPEAKER_01: So they're taking a fiber that the human body cannot digest.
13:44
SPEAKER_01: Right.
13:45
SPEAKER_01: And they break it down, basically handing those extra calories over to the host.
13:48
SPEAKER_00: Precisely that.
13:49
SPEAKER_00: This microbial energy harvesting can contribute an additional 5% to 10%
13:54
SPEAKER_00: of total daily caloric absorption.
13:56
SPEAKER_00: Furthermore,
13:57
SPEAKER_00: these short-chain fatty acids influence the release of gut peptides like GLP-1
14:02
SPEAKER_00: and PYY, which regulate central appetite.
14:05
SPEAKER_00: The microbiome is a critical dynamic gear in the great energy exchange.
14:09
SPEAKER_01: So Medlock Holmes has mapped out this ancient thrifty biology complete
14:13
SPEAKER_01: with suffocating inflammatory fat cells,
14:16
SPEAKER_01: a deaf hypothalamus, and energy harvesting gut bacteria.
14:19
SPEAKER_01: But human genetics haven't fundamentally changed in the last 50 years.
14:22
SPEAKER_00: No, they haven't.
14:23
SPEAKER_01: So why are obesity rates suddenly spiking on a global scale right now?
14:27
SPEAKER_01: This brings us to the external environment.
14:30
SPEAKER_01: Researchers, specifically Swinburne, coined the term the obesogenic environment.
14:35
SPEAKER_00: The obesogenic environment is the catalyst that ignites the genetic vulnerability.
14:40
SPEAKER_00: The modern industrialized landscape is overflowing with highly palatable,
14:45
SPEAKER_00: ultra processed, calorically dense foods.
14:48
SPEAKER_01: They are everywhere.
14:49
SPEAKER_00: Yes.
14:50
SPEAKER_00: These foods are engineered for maximum flavor.
14:52
SPEAKER_00: They are relentlessly marketed.
14:54
SPEAKER_00: They are heavily subsidized, making them incredibly cheap.
14:57
SPEAKER_00: And they are ubiquitous.
14:58
SPEAKER_01: And we combine this constant caloric availability with the proliferation
15:02
SPEAKER_01: of energy saving devices,
15:04
SPEAKER_01: automobiles,
15:05
SPEAKER_01: elevators,
15:06
SPEAKER_01: sedentary computer based employment and the entire structure
15:09
SPEAKER_01: of modern suburban zoning.
15:10
SPEAKER_00: And you have an environment that actively aggressively promotes a positive energy balance.
15:14
SPEAKER_01: It is a world where expending energy actually requires a deliberate,
15:18
SPEAKER_01: often expensive, and effortful choice.
15:20
SPEAKER_01: You have to actively decide to schedule an hour to go to a gym and you have to pay
15:23
SPEAKER_01: for it,
15:23
SPEAKER_01: whereas our ancestors expended thousands of calories simply securing their next meal
15:27
SPEAKER_01: and surviving the elements.
15:29
SPEAKER_00: Making a purposeful,
15:30
SPEAKER_00: deliberate choice to expend energy is directly at odds
15:34
SPEAKER_00: with humanity's biological imperative to conserve it.
15:38
SPEAKER_00: We are biologically hardwired to be extremely vulnerable to overeating when food is present.
15:43
SPEAKER_00: And to rest whenever physical exertion is not strictly necessary.
15:47
SPEAKER_01: So the environment is basically weaponizing our own biology against us.
15:50
SPEAKER_00: Exactly.
15:51
SPEAKER_00: We have built a world with endless cues for consumption and inactivity.
15:56
SPEAKER_00: It is an ideal, highly toxic setting for the obesity epidemic to flourish.
16:00
SPEAKER_00: In fact,
16:01
SPEAKER_00: many researchers and public health experts point out that combating this epidemic on
16:05
SPEAKER_00: a clinical level is nearly impossible without global food policy reform.
16:09
SPEAKER_01: Which usually includes proposals like implementing taxation on sugary foods
16:12
SPEAKER_01: and beverages,
16:13
SPEAKER_01: subsidizing whole foods and restructuring urban environments
16:16
SPEAKER_01: to artificially correct this mismatch.
16:19
SPEAKER_00: Right.
16:19
SPEAKER_00: Though we should note that is a highly debated topic among lobbyists and policymakers.
16:24
SPEAKER_01: Definitely.
16:25
SPEAKER_01: But the interaction goes deeper than just the physical availability of the food.
16:28
SPEAKER_01: We have to look at how that ultra-processed environment interacts with our neuroanatomy.
16:33
SPEAKER_01: Let's explore food addiction and the reward circuitry.
16:37
SPEAKER_01: Because it is not just that a donut is sitting on the counter.
16:40
SPEAKER_01: It is what the sugar and fat in that donut do to our dopamine pathways.
16:45
SPEAKER_00: This represents a crucial intersection of psychiatry and metabolic medicine.
16:50
SPEAKER_00: Ultra-processed foods are engineered to bypass our natural satiety mechanisms.
16:55
SPEAKER_00: When an individual consumes these highly palatable foods,
16:58
SPEAKER_00: which often combine fats and refined carbohydrates in ratios rarely found in nature,
17:03
SPEAKER_00: it triggers a massive release of dopamine in the brain's reward centers,
17:07
SPEAKER_00: particularly the nucleus accumbens.
17:09
SPEAKER_01: It is an artificial neurological reward.
17:11
SPEAKER_01: But what happens when that circuit is activated relentlessly day after day?
17:14
SPEAKER_00: While the brain is highly adaptive,
17:16
SPEAKER_00: recurrent exposure to these massive dopamine spikes leads to neuroadaptation.
17:21
SPEAKER_00: Specifically,
17:22
SPEAKER_00: the brain down regulates its D2 dopamine receptors to protect itself from
17:26
SPEAKER_00: the unnatural, intense stimulation.
17:29
SPEAKER_01: And what's the clinical result of that?
17:30
SPEAKER_00: As a direct result of this receptor downregulation,
17:34
SPEAKER_00: the individual experiences a blunted reward response.
17:37
SPEAKER_00: They must consume larger and larger amounts of the hyperpalatable food just to feel
17:42
SPEAKER_00: the same baseline level of satisfaction, comfort, or reward.
17:46
SPEAKER_01: That mechanism perfectly mirrors the tolerance development we see
17:50
SPEAKER_01: in severe substance use disorders.
17:52
SPEAKER_01: I mean, it is the exact same pathway as cocaine or alcohol dependence.
17:56
SPEAKER_00: The neurobiological parallels are undeniable.
17:59
SPEAKER_00: This mechanism creates a relentless,
18:01
SPEAKER_00: escalating cycle of overeating,
18:02
SPEAKER_00: which is clinically captured by the term food addiction or FA.
18:06
SPEAKER_00: To measure this phenomenon, researchers developed the Yale Food Addiction Scale, the YFAS.
18:11
SPEAKER_01: And that scale is based on DSM criteria, right?
18:13
SPEAKER_00: Yes, it ingeniously applies the DSM-IV diagnostic criteria
18:17
SPEAKER_00: for substance dependence directly to eating behaviors.
18:20
SPEAKER_00: It assesses tolerance,
18:21
SPEAKER_00: withdrawal symptoms like severe agitation when cutting out sugar loss of control,
18:25
SPEAKER_00: and continued use despite negative physical or psychological consequences.
18:29
SPEAKER_01: And what does the prevalence data from the YFAS actually reveal?
18:33
SPEAKER_01: How common is this physiological addiction to food?
18:36
SPEAKER_00: The numbers are staggering.
18:38
SPEAKER_00: A comprehensive 2014 meta-analysis demonstrated that the mean prevalence
18:42
SPEAKER_00: of food addiction is approximately 19.9% across general adult samples.
18:48
SPEAKER_01: Roughly one in five adults in the general population.
18:50
SPEAKER_00: Yes.
18:51
SPEAKER_00: However, that rate doubles to nearly 25% in populations diagnosed with overweight or obesity.
18:57
SPEAKER_00: And when we examine clinical samples of patients with disordered eating,
19:00
SPEAKER_00: the prevalence of food addiction skyrockets to 57.6%.
19:03
SPEAKER_00: Wow.
19:03
SPEAKER_00: Over half.
19:06
SPEAKER_00: This deeply physiological neuroadapted addiction to highly palatable foods is
19:11
SPEAKER_00: a primary engine driving the modern obesity epidemic.
19:14
SPEAKER_01: And that constant downregulation of dopamine receptors doesn't just make
19:18
SPEAKER_01: the patient want more food.
19:19
SPEAKER_01: It actively fractures their psychological relationship with eating.
19:22
SPEAKER_01: Which leads us perfectly into the dimensions of personality and cognition,
19:26
SPEAKER_01: because not everyone exposed to the obesogenic environment develops obesity
19:29
SPEAKER_01: or food addiction.
19:30
SPEAKER_00: That's true.
19:30
SPEAKER_00: People vary drastically in how they process internal distress.
19:34
SPEAKER_01: Right.
19:34
SPEAKER_01: Let's unpack the concept of emotional eating.
19:37
SPEAKER_00: Emotional eating is rooted in affect regulation theory.
19:40
SPEAKER_00: Many individuals report eating in direct,
19:42
SPEAKER_00: immediate response to negative emotional states,
19:46
SPEAKER_00: severe anxiety, profound sadness, loneliness, or even chronic boredom and fatigue.
19:51
SPEAKER_01: They're trying to escape the feeling.
19:52
SPEAKER_00: When internal distress becomes intolerable, the human psyche seeks escape.
19:58
SPEAKER_00: Some individuals utilize psychological suppression,
20:00
SPEAKER_00: some engage in social isolation,
20:02
SPEAKER_00: and a significant number utilize food consumption as
20:05
SPEAKER_00: a behavioral avoidance strategy.
20:07
SPEAKER_00: The act of eating,
20:09
SPEAKER_00: particularly hyperpalatable comfort foods,
20:12
SPEAKER_00: serves to temporarily blunt or suppress that emotional distress.
20:16
SPEAKER_01: It functions as an acute, easily accessible tranquilizer.
20:19
SPEAKER_00: A very effective but highly transient tranquilizer.
20:23
SPEAKER_00: This pattern often begins early in childhood.
20:25
SPEAKER_00: A child experiences distress and a caregiver provides a sweet treat to soothe them.
20:30
SPEAKER_00: It becomes a deeply learned conditioned response to distress.
20:33
SPEAKER_01: So it's wired in early.
20:34
SPEAKER_00: Over time, it solidifies into a primary maladaptive affect regulation tool in adulthood.
20:40
SPEAKER_00: The patient ceases to eat for nutritional satiety.
20:43
SPEAKER_00: They eat solely for emotional regulation.
20:46
SPEAKER_00: Naturally,
20:46
SPEAKER_00: this behavioral pattern is positively associated with
20:49
SPEAKER_00: a significantly higher trajectory of weight gain and elevated BMI over the lifespan.
20:54
SPEAKER_01: And the sources point out that specific personality traits act
20:57
SPEAKER_01: as major vulnerabilities or protectors here.
21:00
SPEAKER_01: The big five personality traits play a significant role, specifically neuroticism.
21:04
SPEAKER_00: Yes.
21:05
SPEAKER_01: Which manifests as greater baseline anxiety, emotional vulnerability and impulsivity.
21:10
SPEAKER_01: That is a heavily documented risk factor for overweight and obesity,
21:13
SPEAKER_01: particularly observed in women.
21:15
SPEAKER_00: Because an individual
21:16
SPEAKER_00: with high neuroticism experiences negative emotions more frequently and intensely,
21:20
SPEAKER_00: creating more trigger points for emotional eating.
21:23
SPEAKER_00: Additionally,
21:24
SPEAKER_00: individuals with a high sensitivity to reward those who are highly responsive
21:28
SPEAKER_00: to environmental cues like the smell of a bakery show and increase proclivity
21:32
SPEAKER_00: toward uncontrolled eating.
21:34
SPEAKER_01: Conversely, high levels of conscientiousness act as a powerful protective factor, right?
21:39
SPEAKER_00: Conscientiousness involves the ability to delay gratification,
21:43
SPEAKER_00: regulate internal urges, plan ahead, and adhere to long-term goals.
21:47
SPEAKER_00: Individuals high in this trait are remarkably protected
21:50
SPEAKER_00: against significant weight gain, even within the obesogenic environment.
21:54
SPEAKER_01: Because they can override the immediate biological impulse with top down cognitive control.
22:00
SPEAKER_00: Exactly.
22:01
SPEAKER_00: When you are sitting across from a patient in the clinic,
22:03
SPEAKER_00: you must assess these personality dimensions.
22:05
SPEAKER_00: They dictate the patient's specific psychological vulnerability to the environment.
22:10
SPEAKER_01: So Medlock Holmes has meticulously mapped out the gears.
22:13
SPEAKER_01: We have the thrifty genetics,
22:15
SPEAKER_01: the suffocating adipocytes,
22:17
SPEAKER_01: the energy-harvesting microbiome,
22:19
SPEAKER_01: the toxic environment,
22:20
SPEAKER_01: the down-regulated dopamine circuits, and the underlying personality traits.
22:24
SPEAKER_00: It's a massive system.
22:25
SPEAKER_01: It really is.
22:26
SPEAKER_01: And now he steps into a new,
22:28
SPEAKER_01: far darker chamber of the laboratory to examine the consequences
22:32
SPEAKER_01: of this malfunctioning machinery.
22:34
SPEAKER_01: Let's explore the clinical manifestations, starting with the medical map.
22:38
SPEAKER_00: The physical toll of severe obesity is systemic, progressive, and devastating.
22:44
SPEAKER_00: It spares virtually no organ system.
22:46
SPEAKER_00: As BMI increases,
22:48
SPEAKER_00: particularly above 35,
22:50
SPEAKER_00: the risk of mortality and severe morbidity rises exponentially.
22:54
SPEAKER_01: What are we looking at specifically?
22:55
SPEAKER_00: We are looking at a cascade of pathology.
22:58
SPEAKER_00: Congestive heart failure,
22:59
SPEAKER_00: coronary artery disease,
23:01
SPEAKER_00: hypertension driven by increased sympathetic tone,
23:04
SPEAKER_00: type 2 diabetes stemming from the insulin resistance we discussed earlier,
23:08
SPEAKER_00: Severe dyslipidemia,
23:09
SPEAKER_00: obstructive sleep apnoia, asthma, osteoarthritis due to mechanical loading.
23:14
SPEAKER_01: And it affects the liver and reproductive systems as well.
23:16
SPEAKER_00: Yes.
23:16
SPEAKER_00: Non-alcoholic fatty liver disease,
23:18
SPEAKER_00: gallbladder disease,
23:19
SPEAKER_00: reproductive infertility,
23:21
SPEAKER_00: polycystic ovarian syndrome,
23:23
SPEAKER_00: and a significantly elevated risk for several forms of cancer,
23:26
SPEAKER_00: including breast, colon, and endometrial cancer.
23:29
SPEAKER_01: The statistics are incredibly grim.
23:31
SPEAKER_01: Obesity and overweight conditions contribute to
23:33
SPEAKER_01: an estimated 300,000 preventable deaths every single year in
23:36
SPEAKER_01: the United States alone.
23:37
SPEAKER_01: It is rapidly approaching tobacco use as the leading cause of preventable death globally.
23:41
SPEAKER_00: But as mental health professionals,
23:43
SPEAKER_00: our clinical focus is drawn heavily to the psychiatric map on the wall.
23:47
SPEAKER_00: And Medlock Holmes,
23:48
SPEAKER_00: observing this map,
23:49
SPEAKER_00: refuses to draw simple, unidirectional arrows from obesity to mental illness.
23:55
SPEAKER_01: No, the arrows are decidedly bidirectional and deeply entangled.
23:59
SPEAKER_01: Let us examine the relationship between obesity and depression.
24:02
SPEAKER_01: The incidence of clinical depression among patients presenting with obesity is remarkably high.
24:07
SPEAKER_01: Prevalence estimates range from 19% to 66%, depending on the clinical setting.
24:12
SPEAKER_00: The reciprocal nature of this loop is fascinating, and it is crucial for trainees to grasp.
24:17
SPEAKER_00: The data indicates that 80% of studies suggest obesity actively contributes to
24:21
SPEAKER_00: the development of depression.
24:22
SPEAKER_01: Through both psychosocial and biological mechanisms, right?
24:25
SPEAKER_00: Yes.
24:26
SPEAKER_00: Psychosocially,
24:26
SPEAKER_00: you have the devastating impact of weight-based societal stigma,
24:30
SPEAKER_00: poor body image,
24:31
SPEAKER_00: decreased physical mobility,
24:33
SPEAKER_00: and overall functional impairment,
24:35
SPEAKER_00: all of which systematically degrade a patient's quality of life.
24:38
SPEAKER_01: And biologically.
24:39
SPEAKER_00: Biologically,
24:40
SPEAKER_00: the systemic inflammation originating from those sick fat cells can cross
24:44
SPEAKER_00: the blood-brain barrier.
24:46
SPEAKER_00: This induces neuroinflammation,
24:47
SPEAKER_00: sickness behavior, and manifests clinically as depressive symptoms.
24:51
SPEAKER_01: Conversely,
24:52
SPEAKER_01: 53% of studies suggest that clinical depression directly leads to the development
24:57
SPEAKER_01: of obesity.
24:58
SPEAKER_00: Which makes sense when you consider the diagnostic criteria
25:00
SPEAKER_00: for major depressive disorder in the DSM-5.
25:03
SPEAKER_00: Atypical depression specifically features increased appetite and hypersomnia.
25:07
SPEAKER_01: And depression elevates the body's stress reaction via the chronic activation of
25:12
SPEAKER_01: the HPA axis, right?
25:14
SPEAKER_00: Yes, the hypothalamic-pituitary-agenal axis.
25:17
SPEAKER_00: This chronic hypercortisolemia actively promotes the storage of visceral fat.
25:22
SPEAKER_00: Furthermore,
25:22
SPEAKER_00: depression brings pervasive negative cognitions,
25:25
SPEAKER_00: profound anhedonia,
25:27
SPEAKER_00: poorer adherence to medical regimens,
25:29
SPEAKER_00: social withdrawal,
25:30
SPEAKER_00: and a deep neurochemically driven craving for high sugar and high fat comfort foods.
25:35
SPEAKER_01: As a desperate attempt to self-medicate the low mood,
25:38
SPEAKER_01: it is a vicious self-sustaining metabolic and psychological loop.
25:42
SPEAKER_01: The depression causes the weight gain,
25:43
SPEAKER_01: which causes the inflammation and stigma, which deepens the depression.
25:47
SPEAKER_00: And demographic factors heavily moderate this relationship.
25:51
SPEAKER_00: The data shows that women,
25:53
SPEAKER_00: individuals of increasing age,
25:54
SPEAKER_00: and particularly those belonging to lower socioeconomic brackets,
25:58
SPEAKER_00: are far more likely to experience this severe comorbidity.
26:02
SPEAKER_01: Moreover,
26:02
SPEAKER_01: the subjective experience of weight stigma being judged or discriminated against
26:07
SPEAKER_01: by healthcare providers or society directly and independently increases
26:11
SPEAKER_01: the likelihood of developing depression.
26:13
SPEAKER_00: The relationship between obesity and anxiety disorders is slightly different,
26:17
SPEAKER_00: though equally complex.
26:19
SPEAKER_00: Anxiety is the most common psychological disorder,
26:21
SPEAKER_00: affecting roughly 25% of the general population.
26:24
SPEAKER_00: The perspective,
26:25
SPEAKER_00: longitudinal evidence suggesting that obesity directly causes generalized anxiety,
26:29
SPEAKER_00: is relatively weak.
26:30
SPEAKER_01: However,
26:31
SPEAKER_01: there is a clear positive association,
26:33
SPEAKER_01: particularly as BMI crosses into the severe obesity categories.
26:37
SPEAKER_01: The strongest links there are with specific phobias and social phobia.
26:40
SPEAKER_01: I have to imagine that is heavily tied to the distress and anticipation
26:43
SPEAKER_01: of weight related stigma in public spaces.
26:46
SPEAKER_01: A patient avoids social gatherings because they fear not fitting into a chair
26:50
SPEAKER_01: or being judged while eating, which clinically manifests as social anxiety.
26:55
SPEAKER_00: That anticipatory anxiety leads to profound isolation.
26:58
SPEAKER_00: And interestingly,
26:59
SPEAKER_00: while PTSD is no longer categorized solely as an anxiety disorder in the DSM-5,
27:05
SPEAKER_00: it shares a profound mechanistic link with obesity.
27:08
SPEAKER_01: This is often mediated through severe childhood trauma,
27:10
SPEAKER_01: such as physical or sexual abuse, isn't it?
27:12
SPEAKER_00: Yes, the anxiety and hyperarousal develop in direct response to the trauma.
27:16
SPEAKER_00: The resulting chronic HPA axis dysfunction drives severe cravings and
27:21
SPEAKER_00: the patient utilizes binge eating behaviors as a psychological coping mechanism
27:25
SPEAKER_00: to numb the trauma related hyperarousal.
27:28
SPEAKER_00: This ultimately leads to severe obesity.
27:30
SPEAKER_01: That concept eating to numb trauma transitions us perfectly into
27:34
SPEAKER_01: the eating disorders themselves.
27:35
SPEAKER_01: These are incredibly common psychiatric comorbidities that demand careful assessment.
27:40
SPEAKER_01: Let's break down binge eating disorder,
27:41
SPEAKER_01: or BED, which is now a standalone formal diagnosis in the DSM-5.
27:45
SPEAKER_01: Yes,
27:45
SPEAKER_00: it is.
27:46
SPEAKER_01: What are the clinical hallmarks a registrar needs to look out for during an intake evaluation?
27:50
SPEAKER_00: Binge eating disorder is characterized by recurrent episodes of eating
27:54
SPEAKER_00: a definitively larger than normal amount of food within a discrete short period
27:58
SPEAKER_00: of time, typically under two hours.
28:02
SPEAKER_00: But the critical psychological hallmark,
28:04
SPEAKER_00: the absolute core of the diagnosis,
28:06
SPEAKER_00: is the patient's profound,
28:08
SPEAKER_00: terrifying feeling of a loss of control during the episode.
28:11
SPEAKER_01: They feel like they literally cannot stop.
28:13
SPEAKER_00: They feel they cannot stop eating or control what or how much they are consuming.
28:19
SPEAKER_00: To meet the formal DSM-5 criteria,
28:21
SPEAKER_00: these episodes must be accompanied by at least three associated symptoms.
28:25
SPEAKER_01: Such as?
28:26
SPEAKER_00: Eating much more rapidly than normal,
28:28
SPEAKER_00: eating until feeling uncomfortably or painfully full,
28:31
SPEAKER_00: eating large amounts of food when not physically hungry,
28:33
SPEAKER_00: eating alone due to deep embarrassment over the quantity consumed,
28:37
SPEAKER_00: or feeling immense guilt, depression, or profound disgust with oneself afterward.
28:42
SPEAKER_01: So if I have a patient who meets those criteria,
28:44
SPEAKER_01: how do I differentiate them from a patient with bulimia nervosa?
28:48
SPEAKER_00: The crucial differentiator is the absolute absence of recurrent compensatory behaviors.
28:53
SPEAKER_00: A patient with BED does not engage in self-induced vomiting,
28:57
SPEAKER_00: they do not misuse laxatives or diuretics,
28:59
SPEAKER_00: they do not engage in frantic compensatory overexercising,
29:03
SPEAKER_00: and they do not implement severe fasting periods to offset the binge.
29:07
SPEAKER_01: The calories remain in the system.
29:08
SPEAKER_00: Exactly.
29:09
SPEAKER_00: Furthermore,
29:10
SPEAKER_00: these binge episodes must cause marked psychological distress and occur,
29:15
SPEAKER_00: on average, at least once a week for a duration of three months.
29:19
SPEAKER_00: It is currently the most common eating disorder globally,
29:22
SPEAKER_00: with a general population prevalence of about 2%.
29:24
SPEAKER_01: However,
29:25
SPEAKER_01: among patients presenting to weight loss clinics with severe obesity,
29:29
SPEAKER_01: the prevalence of BED is estimated to be as high as 30%.
29:32
SPEAKER_00: 30%.
29:34
SPEAKER_00: That is nearly a third of your patients presenting with obesity
29:37
SPEAKER_00: who are secretly struggling with this deeply shameful loss of control binging.
29:41
SPEAKER_00: You have to screen for it because they often won't volunteer the information due to the guilt.
29:45
SPEAKER_01: But BED isn't the only maladaptive eating pattern.
29:48
SPEAKER_01: Let's discuss night eating syndrome, or NES.
29:51
SPEAKER_00: NES is a fascinating historically understudy disorder characterized by
29:55
SPEAKER_00: a significant circadian delay in food consumption.
29:59
SPEAKER_00: The proposed research criteria require either evening hyperphagia,
30:03
SPEAKER_00: which is defined as consuming at least 25% to 50% of total daily caloric intake
30:08
SPEAKER_00: after the evening meal,
30:09
SPEAKER_00: or recurrent nocturnal awakenings accompanied by food ingestion.
30:13
SPEAKER_01: Occurring at least twice a week, right?
30:15
SPEAKER_00: Yes.
30:15
SPEAKER_00: And this is usually accompanied by morning anorexia.
30:31
SPEAKER_00: Yes, the patient routinely skips breakfast because they are simply not hungry
30:34
SPEAKER_00: until much later in the day.
30:36
SPEAKER_00: There is also severe insomnia,
30:38
SPEAKER_00: a notably depressed evening mood that worsens as the night progresses,
30:42
SPEAKER_00: and the deeply held,
30:43
SPEAKER_00: often frantic belief that one must eat in order to initiate or return to sleep.
30:48
SPEAKER_01: The sources mentioned a really nuanced clinical pearl here regarding the nocturnal awakenings.
30:52
SPEAKER_00: Yes.
30:53
SPEAKER_00: Patients who actually experience the nocturnal awakenings to eat exhibit
30:57
SPEAKER_00: a far more severe psychological distress profile.
31:00
SPEAKER_00: They suffer from significantly higher rates of comorbid mood
31:03
SPEAKER_00: and anxiety disorders compared to patients who only experience
31:07
SPEAKER_00: the evening hyperphagia before initially going to bed.
31:10
SPEAKER_01: That is a brilliant distinction.
31:12
SPEAKER_01: Waking from sleep to eat equals a higher index of psychopathology.
31:17
SPEAKER_01: And what about graze eating?
31:18
SPEAKER_01: This sounds less like an acute episode and more like continuous nibbling throughout
31:23
SPEAKER_01: the entire day.
31:24
SPEAKER_00: Graze eating is less formally codified in the DSM, but it is highly clinically relevant.
31:29
SPEAKER_00: It involves eating small to moderate amounts of food continuously,
31:32
SPEAKER_00: often slowly,
31:34
SPEAKER_00: over extended periods of the day,
31:36
SPEAKER_00: almost always for reasons other than physiological hunger.
31:39
SPEAKER_01: Do they feel that same loss of control?
31:40
SPEAKER_00: Interestingly,
31:41
SPEAKER_00: a 2016 psychological study evaluating bariatric surgery candidates found that
31:45
SPEAKER_00: the vast majority of patients who graze E do not experience that terrifying feeling
31:49
SPEAKER_00: of loss of control.
31:51
SPEAKER_00: They are aware they are doing it,
31:52
SPEAKER_00: but they just endorse higher overall emotional distress and use grazing as
31:55
SPEAKER_00: a low-level constant suiting mechanism.
31:58
SPEAKER_01: But some do feel lots of control, right?
32:00
SPEAKER_00: Yes, and the minority of patients who do experience a subjective loss of control
32:04
SPEAKER_00: while grazing report an exceptionally high risk of severe psychopathology
32:08
SPEAKER_00: and poor outcomes.
32:09
SPEAKER_01: So across bed, bed, NES,
32:11
SPEAKER_01: and grazing,
32:12
SPEAKER_01: the presence or absence of that subjective loss of control feeling is
32:16
SPEAKER_01: a massive defining indicator of psychological severity.
32:20
SPEAKER_00: It is the defining line between a maladaptive habit and a severe psychiatric disorder.
32:25
SPEAKER_01: Okay, Medlock Holmes now enters perhaps the most treacherous and complex chamber in
32:29
SPEAKER_01: the entire metabolic laboratory, the psychiatric dispensary.
32:33
SPEAKER_00: This is a critical area.
32:34
SPEAKER_01: This is where the clinicians' integration of knowledge
32:37
SPEAKER_01: and their clinical reasoning are put to the ultimate test.
32:40
SPEAKER_01: We're talking about the intersection of severe mental illness
32:43
SPEAKER_01: or SMI conditions like schizophrenia and bipolar disorder and iatrogenic,
32:47
SPEAKER_01: meaning medically induced, weight gain.
32:50
SPEAKER_00: The epidemiological statistics in this area are profoundly sobering.
32:53
SPEAKER_00: Up to 60% of patients living with schizophrenia and bipolar disorder suffer
32:57
SPEAKER_00: from comorbid obesity.
32:59
SPEAKER_01: Consequentially,
33:00
SPEAKER_01: they possess a vastly increased disproportionate risk
33:03
SPEAKER_01: of developing metabolic syndrome,
33:05
SPEAKER_01: type 2 diabetes, and severe cardiovascular disease.
33:08
SPEAKER_00: Individuals with SMI have a significantly truncated lifespan,
33:12
SPEAKER_00: often reduced by 10 to 25 years compared to the general population.
33:17
SPEAKER_00: Tragically,
33:17
SPEAKER_00: they are frequently dying
33:18
SPEAKER_00: from these entirely preventable metabolism-related medical causes rather than from
33:23
SPEAKER_00: the psychiatric illness itself.
33:25
SPEAKER_01: It is a devastating clinical reality.
33:27
SPEAKER_01: While we know some medication-naive patients
33:30
SPEAKER_01: with first-episode psychosis already show baseline metabolic abnormalities,
33:35
SPEAKER_01: the psychotropic medications we as psychiatrists prescribe play
33:38
SPEAKER_01: a massive undeniable role in this excess mortality.
33:42
SPEAKER_00: They absolutely do.
33:43
SPEAKER_01: I used the analogy earlier.
33:44
SPEAKER_01: Prescribing some of these medications is like patching a leaky roof to stop
33:47
SPEAKER_01: the rain, but intentionally flooding the basement in the process.
33:51
SPEAKER_01: How do you effectively treat the severe pathology of the mind
33:53
SPEAKER_01: without utterly destroying the body's metabolic foundation?
33:56
SPEAKER_00: It requires meticulous, proactive clinical reasoning.
34:00
SPEAKER_00: You cannot simply write the prescription, treat the hallucinations, and walk away.
34:04
SPEAKER_00: Let us rigorously unpack the psychotropic weight gain profiles detailed
34:09
SPEAKER_00: in table 27.4 to 5 of the text.
34:12
SPEAKER_01: Let's start with the antipsychotics.
34:13
SPEAKER_00: The atypical antipsychotics,
34:15
SPEAKER_00: the second generation agents, are the most notorious offenders here.
34:19
SPEAKER_00: The heavy hitters causing profound,
34:21
SPEAKER_00: rapid and unrelenting weight gain are olanzapine,
34:24
SPEAKER_00: which can cause an astonishing average gain of 2.3 kilograms per month.
34:29
SPEAKER_01: 2.3 kilos a month.
34:30
SPEAKER_01: That adds over 27 kilos, or roughly 60 pounds, in a single year.
34:35
SPEAKER_01: And the mechanisms behind that are fascinating.
34:37
SPEAKER_00: They are.
34:38
SPEAKER_00: Olanzapine and clozapine are incredibly potent antagonists at
34:41
SPEAKER_00: the histamine H1 receptor and the serotonin 5-HT2C receptor in the hypothalamus.
34:46
SPEAKER_01: Which absolutely obliterates the brain's satiety signaling.
34:49
SPEAKER_01: The patient never feels full.
34:50
SPEAKER_01: Plus, there's evidence they directly alter peripheral insulin sensitivity
34:54
SPEAKER_01: and lipid metabolism, independent of the weight gain.
34:56
SPEAKER_00: The pharmacology is aggressively obesogenic.
34:59
SPEAKER_00: Clozapine follows closely behind olanzapine,
35:02
SPEAKER_00: causing roughly 1.7 kilograms of game per month,
35:06
SPEAKER_00: and quitopine averages 1.8 kilograms per month.
35:09
SPEAKER_01: But these are incredibly effective,
35:11
SPEAKER_01: often life-saving medications for treatment-resistant psychosis or severe mania.
35:16
SPEAKER_00: They are.
35:17
SPEAKER_00: But they drastically reduce resting metabolic rate,
35:20
SPEAKER_00: massively increase appetite,
35:22
SPEAKER_00: particularly cravings for carbohydrates,
35:25
SPEAKER_00: and fundamentally alter how the body partitions caloric intake.
35:28
SPEAKER_01: What about the other psychiatric medication classes?
35:30
SPEAKER_01: We focus heavily on antipsychotics, but what about the antidepressants and the mood stabilizers?
35:35
SPEAKER_00: Within the antidepressant class,
35:36
SPEAKER_00: iatrigetic weight gain is severely under-recognized by primary care providers.
35:41
SPEAKER_00: The older agents,
35:42
SPEAKER_00: specifically the tricyclic antidepressants,
35:44
SPEAKER_00: or TCAs,
35:45
SPEAKER_00: like amitriptyline and the monamine oxidase inhibitors,
35:48
SPEAKER_00: the MAOIs, cause significantly more weight gain than the newer SSRIs.
35:52
SPEAKER_01: What about the newer ones, though?
35:54
SPEAKER_00: Among the newer,
35:55
SPEAKER_00: widely prescribed agents,
35:56
SPEAKER_00: mirtazapine and paroxetine are particularly notorious for inducing moderate
36:00
SPEAKER_00: to severe weight gain.
36:02
SPEAKER_00: Conversely,
36:03
SPEAKER_00: bupropion stands out as the rare,
36:05
SPEAKER_00: highly unique antidepressant that actually acts as an anorexigenic agent,
36:09
SPEAKER_00: actively promoting mild weight loss due to its dopaminergic
36:12
SPEAKER_00: and noradrenergic reuptake inhibition.
36:15
SPEAKER_01: And the mood stabilizers utilized in bipolar disorder management.
36:18
SPEAKER_00: Divalproix,
36:19
SPEAKER_00: commonly known as valproate,
36:21
SPEAKER_00: and lithium both cause significant moderate weight gain,
36:24
SPEAKER_00: frequently ranging from 1 to 15 kilograms over the course of treatment.
36:28
SPEAKER_00: Carbamazepine also causes moderate gain.
36:31
SPEAKER_01: Are there any weight-neutral options?
36:32
SPEAKER_00: Lamotrigine is generally considered weight-neutral,
36:35
SPEAKER_00: making it a highly favorable option for patients
36:38
SPEAKER_00: with pre-existing metabolic concerns.
36:40
SPEAKER_00: Interestingly,
36:41
SPEAKER_00: certain anticonvulsants often used off-label or for comorbid conditions,
36:45
SPEAKER_00: specifically to paramate and zonatsamud,
36:47
SPEAKER_00: Possess appetite suppressing properties and can actually promote weight loss.
36:51
SPEAKER_01: So let's operationalize this.
36:52
SPEAKER_01: What does this actually mean for the psychiatry registrar sitting in
36:56
SPEAKER_01: the emergency department or the outpatient clinic?
36:59
SPEAKER_01: You are evaluating a patient with schizophrenia who is highly symptomatic,
37:03
SPEAKER_01: actively paranoid,
37:04
SPEAKER_01: but they already present with a BMI of 36,
37:07
SPEAKER_01: elevated triglycerides and early stage metabolic syndrome.
37:10
SPEAKER_01: What is your move?
37:11
SPEAKER_00: Your move is extreme vigilance and proactive integrated intervention.
37:16
SPEAKER_00: Clinicians must adhere to stringent metabolic monitoring guidelines.
37:19
SPEAKER_00: This includes regular documented measurement of BMI,
37:23
SPEAKER_00: waist circumference,
37:24
SPEAKER_00: fasting lipid profiles,
37:25
SPEAKER_00: and fasting plasma glucose or HbA1c levels at baseline,
37:29
SPEAKER_00: at 12 weeks, and annually thereafter.
37:32
SPEAKER_01: You have to talk to the patient about it, right?
37:33
SPEAKER_00: You must have an informed consent conversation with the patient regarding the risk
37:37
SPEAKER_00: of weight gain before they swallow the first pill.
37:40
SPEAKER_00: Simultaneously,
37:41
SPEAKER_00: you must provide or refer for active recommendations regarding dietary modification
37:45
SPEAKER_00: and physical exercise as a preventative measure from day one.
37:49
SPEAKER_01: You cannot wait for them to gain 20 kilos over six months before finally bringing up
37:53
SPEAKER_01: a referral to a dietician.
37:55
SPEAKER_01: The horse already left the barn.
37:57
SPEAKER_00: Precisely.
37:58
SPEAKER_00: You must aggressively choose the medication that best treats
38:00
SPEAKER_00: the psychiatric disorder while possessing the lowest possible weight gain profile
38:05
SPEAKER_00: for that specific patient's metabolic reality.
38:08
SPEAKER_00: Perhaps you trial aripiprazole,
38:10
SPEAKER_00: loracidone, or ziprofacidone first as they are largely weight neutral.
38:14
SPEAKER_01: And if they still gain weight.
38:16
SPEAKER_00: If significant weight gain still occurs,
38:18
SPEAKER_00: you must strongly consider safely cross titrating and switching to
38:21
SPEAKER_00: a different antipsychotic.
38:23
SPEAKER_00: Furthermore, you must consider the use of adjunctive treatments.
38:27
SPEAKER_00: This includes referring the patient
38:28
SPEAKER_00: to specialized cognitive behavioral weight management programs tailored
38:32
SPEAKER_00: for individuals with SMI.
38:34
SPEAKER_01: And what about pharmacological adjuncts to counteract the side effects?
38:37
SPEAKER_01: The source material mentioned something fascinating about intervening at
38:40
SPEAKER_01: the gut-brain axis level.
38:42
SPEAKER_00: Yes, this is a rapidly expanding area of psychopharmacology.
38:45
SPEAKER_00: There is a robust,
38:46
SPEAKER_00: emerging literature base demonstrating the clinical efficacy
38:50
SPEAKER_00: of co-prescribing metformin,
38:51
SPEAKER_00: traditionally a first-line antidiabetic drug,
38:54
SPEAKER_00: specifically to mitigate antipsychotic-induced metabolic dysfunction
38:58
SPEAKER_00: and weight gain.
38:59
SPEAKER_01: How does it help with weight?
39:00
SPEAKER_00: Metformin increases peripheral insulin sensitivity and appears to work,
39:04
SPEAKER_00: at least in part,
39:06
SPEAKER_00: via complex changes in the gut microbiome and the gut-brain axis,
39:09
SPEAKER_00: modulating appetite-regulating peptides.
39:12
SPEAKER_00: It is becoming a standard tool in the psychiatric dispensary to protect
39:16
SPEAKER_00: the patient's body while treating their mind.
39:18
SPEAKER_01: We are also seeing profound conceptual parallels when we look at substance use disorders, right?
39:24
SPEAKER_00: The neurobiology of obesity, food addiction, and substance use disorders overlap significantly.
39:29
SPEAKER_00: We discussed the downregulation of the dopamine D2 receptors earlier.
39:33
SPEAKER_01: The overlap is undeniable.
39:35
SPEAKER_01: Drugs of abuse and highly addictive hyperpalatable foods activate
39:39
SPEAKER_01: the exact same regions in the brain involved in reward processing,
39:43
SPEAKER_01: habit formation,
39:44
SPEAKER_01: and decision making,
39:45
SPEAKER_01: specifically the ventral tegmental area and the nucleus accumbens.
39:49
SPEAKER_00: Epidemiologically,
39:50
SPEAKER_00: there is a strong positive relationship between severe nicotine dependence
39:53
SPEAKER_00: and obesity and similarly between alcohol use disorders and obesity.
39:57
SPEAKER_01: Interestingly,
39:58
SPEAKER_01: from a clinical perspective,
40:00
SPEAKER_01: when a patient successfully enters remission for a severe substance use disorder,
40:05
SPEAKER_01: when they finally stop using cocaine or alcohol,
40:08
SPEAKER_01: they very frequently experience rapid significant weight gain.
40:12
SPEAKER_00: This is a form of symptom substitution.
40:14
SPEAKER_00: The brain is desperately seeking dopamine from the only remaining available source,
40:19
SPEAKER_00: highly palatable food.
40:21
SPEAKER_00: Therefore,
40:21
SPEAKER_00: acute awareness of weight management is absolutely critical
40:24
SPEAKER_00: when treating addictions, lest the patient trade one fatal disease for another.
40:29
SPEAKER_01: Treatments that target the underlying reward circuitry
40:32
SPEAKER_01: and improve executive functioning like rigorous cognitive behavioral therapy
40:35
SPEAKER_01: or specific neuromodulating medications can often benefit both
40:39
SPEAKER_01: the substance use recovery and the obesity management simultaneously.
40:43
SPEAKER_00: That level of integration is incredible.
40:45
SPEAKER_00: We are treating the whole system,
40:46
SPEAKER_00: the whole patient,
40:47
SPEAKER_00: not just the isolated symptom of weight or the isolated symptom of psychosis.
40:51
SPEAKER_01: So let's pivot and move fully into the treatment phase.
40:53
SPEAKER_01: We have comprehensively mapped the problem.
40:55
SPEAKER_01: We understand the medications and the mechanisms.
40:58
SPEAKER_01: Now, how do we actually intervene and help the patient sitting in front of us?
41:02
SPEAKER_01: Let's start with behavioral weight loss,
41:04
SPEAKER_01: or BWL, and what I like to call the fundamental 5-10% rule.
41:08
SPEAKER_00: When patients finally begin a dedicated weight loss journey,
41:11
SPEAKER_00: they often arrive in the clinic with monumental,
41:13
SPEAKER_00: sometimes medically unrealistic goals.
41:16
SPEAKER_00: They want to lose 30%,
41:18
SPEAKER_00: 40%, or even half of their total body weight to achieve a societal aesthetic ideal.
41:24
SPEAKER_01: But the biological and clinical reality is profoundly different.
41:28
SPEAKER_00: The foundational rule of obesity medicine is that losing just 5% to 10%
41:32
SPEAKER_00: of their initial body weight yields massive,
41:34
SPEAKER_00: clinically significant improvements across almost all physical domains.
41:38
SPEAKER_01: Just 5 to 10%.
41:39
SPEAKER_01: To put that in perspective,
41:40
SPEAKER_01: if a patient weighs 250 pounds,
41:42
SPEAKER_01: losing just 12
41:43
SPEAKER_01: to 25 pounds fundamentally changes their physiological health trajectory.
41:46
SPEAKER_00: It drastically lowers systolic and diastolic blood pressure,
41:50
SPEAKER_00: significantly improves lipid profiles by lowering LDL and raising HDL,
41:55
SPEAKER_00: and decreases systemic inflammatory markers.
41:58
SPEAKER_00: In patients suffering from type 2 diabetes,
42:00
SPEAKER_00: longitudinal studies show that losing nearly 1 to 9 pounds has been correlated
42:05
SPEAKER_00: with significantly decreased long-term mortality.
42:07
SPEAKER_01: And it improves mental health as well.
42:09
SPEAKER_00: Furthermore,
42:10
SPEAKER_00: even this modest degree
42:11
SPEAKER_00: of weight loss consistently improves critical psychological variables.
42:15
SPEAKER_00: Patients report better body image,
42:16
SPEAKER_00: higher self-esteem,
42:18
SPEAKER_00: reduced depressive symptoms,
42:19
SPEAKER_00: and a marked improvement in overall health-related quality of life.
42:22
SPEAKER_01: The core takeaway for the clinician is to establish this baseline reality with
42:26
SPEAKER_01: the patient early on.
42:28
SPEAKER_01: A weight loss goal is never too small to be profoundly beneficial to their biology.
42:32
SPEAKER_00: And many patients start this process independently through highly marketed commercial diets.
42:37
SPEAKER_00: Weight Watchers, Jenny Craig, South Beach, the ketogenic diet.
42:41
SPEAKER_00: Table 27.4 to 6 in the text breaks these down,
42:44
SPEAKER_00: categorizing them into low calorie balanced diets,
42:47
SPEAKER_00: very low calorie liquid meal replacements, and low carbohydrate models.
42:51
SPEAKER_01: But what does the rigorous scientific literature actually say about
42:55
SPEAKER_01: which specific diet is the physiological best?
42:59
SPEAKER_01: Do we need to force patients to abandon carbohydrates entirely?
43:03
SPEAKER_00: The research on this topic is highly illuminating
43:06
SPEAKER_00: and often contradicts popular media narratives.
43:09
SPEAKER_00: While rapid significant weight loss can certainly be observed
43:12
SPEAKER_00: on stripped low carbohydrate diets or ultra low fat diets,
43:16
SPEAKER_00: long term randomized controlled trials demonstrate that the weight loss differences
43:20
SPEAKER_00: between the specific types of diets are actually clinically minimal at the one year
43:25
SPEAKER_00: and two year marks.
43:26
SPEAKER_01: So the magic metabolic bullet isn't found in perfectly avoiding carbs
43:29
SPEAKER_01: or exclusively eating fats.
43:31
SPEAKER_00: No, it is not.
43:32
SPEAKER_00: When comparing various popular macronutrient programs,
43:35
SPEAKER_00: the research unequivocally indicates that behavioral adherence is
43:38
SPEAKER_00: the single biggest,
43:39
SPEAKER_00: most robust predictor of long term weight loss,
43:41
SPEAKER_00: regardless of the specific macronutrient breakdown of the diet itself.
43:45
SPEAKER_01: It's just whatever you can stick to.
43:46
SPEAKER_00: The absolute best diet for any given patient is simply the one that
43:49
SPEAKER_00: the patient can actually adhere to sustainably over the course of years
43:53
SPEAKER_00: without experiencing severe psychological deprivation.
43:56
SPEAKER_01: And how do we as clinicians help them stick to it?
44:00
SPEAKER_01: Willpower is a finite resource.
44:02
SPEAKER_01: The 2013 medical guidelines heavily endorse the use
44:05
SPEAKER_01: of rigorous multi-component behavioral weight loss, or BWL,
44:10
SPEAKER_01: interventions for anyone presenting with a BMI over 30 or over 25
44:15
SPEAKER_01: with existing comorbidities.
44:16
SPEAKER_00: These BWL interventions are not just about handing the patient a meal plan.
44:20
SPEAKER_00: They are rooted deeply in classical and operant learning theory.
44:24
SPEAKER_00: The primary therapeutic goal is to actively modify the environmental context in
44:28
SPEAKER_00: which the eating behavior occurs.
44:30
SPEAKER_01: Can you give an example?
44:31
SPEAKER_00: You work with the patient
44:32
SPEAKER_00: to reduce maladaptive behaviors like mindlessly eating calorically dense food
44:36
SPEAKER_00: while watching television and meticulously reinforce healthy alternative behaviors.
44:41
SPEAKER_00: It emphasizes psychological flexibility over rigid punishing adherence.
44:46
SPEAKER_00: A major foundational component
44:47
SPEAKER_00: of this behavioral modification is rigorous self-monitoring and goal setting.
44:51
SPEAKER_01: Tracking what you eat, food diaries, calorie counting apps.
44:54
SPEAKER_00: Yes, creating a tangible record.
44:57
SPEAKER_00: But a fascinating,
44:58
SPEAKER_00: highly practical study evaluated exactly what makes self-monitoring effective
45:03
SPEAKER_00: for long-term weight maintenance at the 12-month follow-up mark.
45:06
SPEAKER_00: They looked at three variables, frequency, consistency, and comprehensiveness.
45:11
SPEAKER_01: So how often they log, how consistent they are week to week, and how detailed they are.
45:16
SPEAKER_00: Right.
45:17
SPEAKER_00: Comprehensiveness is how obsessive,
45:19
SPEAKER_00: detailed, and precise the logging was regarding exact grams and macronutrients.
45:24
SPEAKER_01: What was the defining variable for success?
45:26
SPEAKER_00: The individuals who continued to self-monitor frequently
45:29
SPEAKER_00: and consistently successfully sustained their weight loss.
45:32
SPEAKER_00: Strikingly,
45:33
SPEAKER_00: increased comprehensiveness,
45:34
SPEAKER_00: obsessing over every single gram of food,
45:36
SPEAKER_00: weighing every almond,
45:37
SPEAKER_00: and tracking exact macro details did not result in any added weight loss benefit
45:42
SPEAKER_00: above and beyond simply logging frequently.
45:44
SPEAKER_01: Wow.
45:45
SPEAKER_01: So just consistently writing down the fact that you ate a turkey sandwich
45:48
SPEAKER_01: for lunch is vastly more important for long-term success than perfectly measuring
45:53
SPEAKER_01: the exact weight of the turkey breast to the decimal point.
45:55
SPEAKER_00: It is the behavioral habit of continuous self-awareness and accountability
45:59
SPEAKER_00: that maintains the weight loss,
46:00
SPEAKER_00: not the exhausting obsessive precision,
46:03
SPEAKER_00: which often leads to burnout and abandonment of the tracking entirely.
46:07
SPEAKER_01: But behavioral change isn't just about food diaries and stimulus control.
46:11
SPEAKER_01: It is fundamentally about the underlying thoughts driving the urge to eat.
46:15
SPEAKER_01: This is where we compare two heavyweight psychological interventions used
46:19
SPEAKER_01: in obesity management,
46:21
SPEAKER_01: traditional cognitive behavioral therapy,
46:23
SPEAKER_01: CBT, And the newer acceptance and commitment therapy, ACT.
46:27
SPEAKER_01: Let's unpack the mechanisms of CBT first.
46:30
SPEAKER_00: CBT is an empirically supported gold standard psychological intervention.
46:35
SPEAKER_00: It vastly enhances traditional weight loss treatments by directly identifying
46:38
SPEAKER_00: and targeting the maladaptive automatic thoughts that trigger episodes
46:41
SPEAKER_00: of overeating.
46:43
SPEAKER_00: The core therapeutic mechanism at play here is cognitive restructuring.
46:47
SPEAKER_01: Challenging the irrational thoughts.
46:49
SPEAKER_01: Getting into the mental ring and fighting the cognitive distortion.
46:52
SPEAKER_00: Classic all-or-nothing thinking.
47:13
SPEAKER_00: In CBT, the clinician trains the patient to use Socratic questioning
47:17
SPEAKER_00: to actively challenge this catastrophic cognitive distortion.
47:21
SPEAKER_00: The patient learns to ask themselves,
47:23
SPEAKER_00: where is the logical evidence that one 200 calorie cookie ruins an entire week
47:28
SPEAKER_00: of healthy eating?
47:29
SPEAKER_00: Does one flat tire mean I should slash the other three?
47:32
SPEAKER_01: The goal is to elucidate the dysfunctional thought,
47:35
SPEAKER_01: logically challenge it,
47:36
SPEAKER_01: and generate a rational,
47:37
SPEAKER_01: balanced alternative thought in the heat of the moment,
47:40
SPEAKER_01: thereby preventing the escalation into a full binge episode.
47:43
SPEAKER_01: Okay, so CBT is about treating the thought as an enemy to be debated and defeated.
47:48
SPEAKER_01: You demand evidence, you restructure it.
47:50
SPEAKER_01: But then we have ACT,
47:51
SPEAKER_01: Acceptance and Commitment Therapy,
47:52
SPEAKER_01: which is heavily rooted in mindfulness-based principles.
47:56
SPEAKER_01: If CBT is about actively fighting and altering the thought,
47:59
SPEAKER_01: is ACT just about surrendering to it and giving up?
48:02
SPEAKER_00: That is a brilliant way to frame the question,
48:04
SPEAKER_00: and it highlights a major paradigm shift in psychotherapy.
48:08
SPEAKER_00: It is not surrender in the sense of giving up the goal.
48:11
SPEAKER_00: It is surrendering the exhausting struggle against the internal experience itself.
48:15
SPEAKER_00: ACT directly targets a psychological phenomenon known as experiential avoidance.
48:21
SPEAKER_01: Experiential avoidance.
48:27
SPEAKER_00: Highly uncomfortable internal events like severe anxiety,
48:30
SPEAKER_00: intense cravings for sugar, or negative self-judgments.
48:34
SPEAKER_01: Because,
48:34
SPEAKER_01: as we discussed earlier,
48:35
SPEAKER_01: emotional eating is literally a mechanism of experiential avoidance.
48:39
SPEAKER_01: The patient eats a donut specifically to push away the anxiety of a stressful workday.
48:43
SPEAKER_00: Exactly.
48:44
SPEAKER_00: The eating is the avoidance behavior.
48:47
SPEAKER_00: ACT aims to systematically increase the patient's psychological willingness
48:51
SPEAKER_00: to simply experience those negative emotions and cravings without trying
48:56
SPEAKER_00: to immediately suppress them with food.
48:58
SPEAKER_01: How do you do that in therapy?
48:59
SPEAKER_00: In therapy, you utilize techniques like mindfulness and cognitive diffusion.
49:05
SPEAKER_00: Instead of fighting the thought,
49:06
SPEAKER_00: I blew it,
49:07
SPEAKER_00: I am a failure,
49:08
SPEAKER_00: which often just gives the thought more power,
49:10
SPEAKER_00: the patient learns to simply observe it.
49:12
SPEAKER_00: I am noticing that I am having the thought that I am a failure.
49:15
SPEAKER_00: It is just the thought, string of words in my mind.
49:18
SPEAKER_00: I do not have to obey it.
49:19
SPEAKER_01: You diffuse the power of the intense craving.
49:22
SPEAKER_01: You don't fight the urge for the cookie.
49:24
SPEAKER_01: You allow the urge to exist in the room with you.
49:26
SPEAKER_01: You breathe through it and then you consciously align your physical actions
49:30
SPEAKER_01: with your core, deeply held personal values.
49:32
SPEAKER_00: Values such as your long-term desire for health and vitality.
49:36
SPEAKER_01: That is a profound psychological shift.
49:38
SPEAKER_01: You are changing the relationship to the craving.
49:41
SPEAKER_01: Rather than trying to eradicate the craving.
49:43
SPEAKER_01: Does the clinical data support this approach for obesity?
49:46
SPEAKER_00: Strongly.
49:47
SPEAKER_00: A comprehensive 2020 systematic review found
49:51
SPEAKER_00: that ACT based interventions consistently demonstrated significantly greater weight
49:55
SPEAKER_00: loss outcomes than standard behavioral treatments,
49:59
SPEAKER_00: particularly at the 12 month and 24 month follow up marks.
50:03
SPEAKER_01: It holds up over time.
50:05
SPEAKER_00: ACT is exceptionally effective for long term weight maintenance
50:09
SPEAKER_00: because it actively builds psychological flexibility.
50:12
SPEAKER_00: It equips patients to cope with the inevitable new emotional challenges
50:16
SPEAKER_00: and life stressors they will face over the years without automatically reverting
50:20
SPEAKER_00: to food as their primary coping mechanism.
50:22
SPEAKER_01: Which brings us to the ultimate overarching framework
50:25
SPEAKER_01: for understanding how human beings actually undergo complex behavioral change,
50:30
SPEAKER_01: the transtheoretical model,
50:32
SPEAKER_01: or TTM, and the clinical application of motivational interviewing.
50:35
SPEAKER_00: The TTM,
50:36
SPEAKER_00: developed by Prochaska and DiClemente,
50:38
SPEAKER_00: outlines the specific sequential stages of change.
50:42
SPEAKER_00: We begin with the pre-contemplation stage,
50:44
SPEAKER_00: where the patient has little to no intention of changing their behavior in
50:47
SPEAKER_00: the foreseeable future.
50:48
SPEAKER_01: They might not even think it's a problem.
50:50
SPEAKER_00: Right.
50:50
SPEAKER_00: They may be entirely unaware or deeply in denial that their obesity is even a medical problem.
50:56
SPEAKER_00: Then comes the contemplation stage.
50:59
SPEAKER_00: Here, the patient is acutely aware of the problem.
51:02
SPEAKER_00: I know I need to lose weight because my diabetes is worsening,
51:04
SPEAKER_00: but they are deeply painfully stuck in ambivalence,
51:08
SPEAKER_00: constantly weighing the pros and cons of changing versus staying the same.
51:13
SPEAKER_01: And the text mentions that patients can remain completely paralyzed
51:17
SPEAKER_01: in this contemplation stage for years.
51:19
SPEAKER_00: Easily for decades.
51:20
SPEAKER_00: Next is the preparation stage,
51:22
SPEAKER_00: where the patient genuinely intends to take measurable action within the next month.
51:26
SPEAKER_00: They are taking tentative baby steps like purchasing a gym membership,
51:30
SPEAKER_00: downloading a calorie tracking app,
51:32
SPEAKER_00: or buying new running shoes,
51:33
SPEAKER_00: but they haven't actually started the rigorous behavior chain.
51:36
SPEAKER_01: They're getting ready to act.
51:37
SPEAKER_00: Then comes the action stage, where overt, significant behavioral modification occurs.
51:42
SPEAKER_00: This is throwing away the trigger foods, actually sweating in the gym, and logging the meals.
51:46
SPEAKER_00: This stage typically lasts up to six months.
51:49
SPEAKER_01: And then the maintenance stage,
51:50
SPEAKER_01: which focuses entirely on preventing relapse and consolidating the hard-won gains
51:55
SPEAKER_01: for over six months, potentially lasting for a lifetime.
51:58
SPEAKER_00: And finally,
51:58
SPEAKER_00: termination,
51:59
SPEAKER_00: where the cycle of change is theoretically complete and
52:02
SPEAKER_00: the patient experiences zero temptation to return to old habits.
52:06
SPEAKER_00: Though many obesity experts argue that maintenance is a lifelong permanent stage
52:11
SPEAKER_00: for severe weight management.
52:13
SPEAKER_01: But here is the critical, often frustrating clinical reality check for the trainee.
52:18
SPEAKER_01: Movement through these stages is almost never a clean linear path.
52:22
SPEAKER_01: It is a spiral.
52:24
SPEAKER_01: Relapse is a statistical rule, not the exception.
52:27
SPEAKER_01: Patients will frequently and repeatedly regress to earlier stages.
52:30
SPEAKER_00: Yes.
52:31
SPEAKER_00: A patient in the maiming stage might go to a stressful family holiday party,
52:35
SPEAKER_00: experience a severe binge episode,
52:37
SPEAKER_00: feel overwhelmed by shame,
52:38
SPEAKER_00: and regress all the way back to the contemplation stage,
52:41
SPEAKER_00: feeling deeply ambivalent about whether they possess the capability to ever succeed.
52:45
SPEAKER_01: This spiral nature is exactly why stage matching the clinical intervention is
52:49
SPEAKER_01: so incredibly crucial.
52:51
SPEAKER_01: Let's look at the textbook's case study of Robin.
52:54
SPEAKER_01: She's a 24-year-old patient with a BMI of 40,
52:57
SPEAKER_01: struggling with severe binge eating
52:58
SPEAKER_01: and profound social anxiety regarding her weight.
53:02
SPEAKER_01: She tells the clinic she desperately wants to change,
53:04
SPEAKER_01: but week after week she completely fails to complete her food monitoring forms
53:09
SPEAKER_01: and misses all of her prescribed exercise goals.
53:12
SPEAKER_00: An inexperienced or novice clinician looks at Robin,
53:15
SPEAKER_00: hears her say, I want help, and falsely assumes she is firmly in the action stage.
53:21
SPEAKER_00: Consequentially,
53:22
SPEAKER_00: the clinician will attempt to aggressively problem solve the logistical barriers.
53:26
SPEAKER_00: They will say,
53:27
SPEAKER_00: let's get you a louder alarm clock so you can wake up for the gym,
53:30
SPEAKER_00: or let's use a simpler, more colorful app for your food tracking.
53:33
SPEAKER_01: And Robin will inevitably fail again,
53:35
SPEAKER_01: feel deeper shame, and likely drop out of treatment entirely.
53:39
SPEAKER_00: Because Robin wasn't actually in the action stage.
53:41
SPEAKER_00: She was deeply stuck in contemplation.
53:44
SPEAKER_00: She was grounding in internal ambivalence and suffered from incredibly low self-efficacy.
53:49
SPEAKER_00: She didn't believe she could actually do it.
53:51
SPEAKER_01: Precisely.
53:52
SPEAKER_01: The expert clinician recognizes this stage mismatch immediately.
53:56
SPEAKER_01: Instead of pushing external,
53:58
SPEAKER_01: action-oriented tasks on an ambivalent patient,
54:01
SPEAKER_01: the expert pivots to motivational interviewing, or MI.
54:04
SPEAKER_00: MI is a highly collaborative,
54:06
SPEAKER_00: empathetic,
54:07
SPEAKER_00: person-centered,
54:08
SPEAKER_00: conversational style designed specifically to elicit and strengthen
54:12
SPEAKER_00: a patient's own intrinsic motivation for change.
54:15
SPEAKER_00: The clinician uses open-ended questions and complex reflections to highlight
54:20
SPEAKER_00: the discrepancies between Robin's stated core values,
54:23
SPEAKER_00: such as her deep desire to socialize and travel without anxiety,
54:26
SPEAKER_00: and her current avoidant actions.
54:28
SPEAKER_01: The clinician explores the ambivalence deeply, without judgment.
54:31
SPEAKER_01: They ask things like, what makes you want to change?
54:33
SPEAKER_01: And simultaneously, what makes the idea of changing feel so terrifying?
54:37
SPEAKER_00: Yes.
54:37
SPEAKER_00: By exploring and resolving that ambivalence internally within the patient,
54:41
SPEAKER_00: rather than having the clinician dictate a meal plan externally,
54:44
SPEAKER_00: Robin slowly builds the intrinsic motivation necessary to actually move herself into
54:48
SPEAKER_00: the preparation and eventually the action stage.
54:51
SPEAKER_01: The clinical trials show
54:52
SPEAKER_01: that utilizing MI significantly enhances long-term weight loss outcomes above and
54:57
SPEAKER_01: beyond standard directive advice-giving interventions.
55:01
SPEAKER_00: That delicate navigation of ambivalence is the true art of psychiatry right there.
55:05
SPEAKER_01: It really is.
55:06
SPEAKER_01: But we also have to acknowledge reality.
55:08
SPEAKER_01: Sometimes behavioral modification,
55:10
SPEAKER_01: perfect diets,
55:11
SPEAKER_01: and expert psychotherapy are simply not enough to overcome the immense power
55:15
SPEAKER_01: of evolutionary biology and genetics.
55:18
SPEAKER_01: We must discuss the medical and surgical frontiers.
55:22
SPEAKER_01: The
55:24
SPEAKER_00: clinical guidelines state that medications specifically
55:26
SPEAKER_00: for weight loss are indicated as an adjunct treatment for patients with
55:29
SPEAKER_00: a BMI greater than 30 or a BMI greater than 27
55:33
SPEAKER_00: with serious obesity-related comorbidities like hypertension or diabetes.
55:38
SPEAKER_01: However, a major caveat.
55:40
SPEAKER_01: It is a dark history.
55:40
SPEAKER_01: Historically, the pursuit of pharmacological weight loss has caused immense harm.
55:44
SPEAKER_01: Amphetamines were heavily used,
55:45
SPEAKER_01: leading to severe widespread substance abuse and psychiatric crises.
56:03
SPEAKER_00: The combination of fenfluramine and phentermine,
56:06
SPEAKER_00: known as fenfen,
56:07
SPEAKER_00: caused devastating valvular heart disease and pulmonary hypertension.
56:11
SPEAKER_00: Ephedrine was linked to significant cardiovascular mortality.
56:14
SPEAKER_01: Because of this, the FDA and medical bodies are exceptionally cautious.
56:19
SPEAKER_01: Currently, we have several approved SAFER agents.
56:23
SPEAKER_01: Orlistat, for example, operates entirely in the gut, right?
56:26
SPEAKER_00: Yes, it is a lipase inhibitor that physically blocks the absorption of roughly 30%
56:30
SPEAKER_00: of dietary fat.
56:31
SPEAKER_00: It yields about an 11% weight loss over a year.
56:34
SPEAKER_00: However,
56:35
SPEAKER_00: because that unabsorbed fat remains in the GI tract,
56:38
SPEAKER_00: it comes with severe gastrointestinal distress,
56:40
SPEAKER_00: oily spotting, urgent stools, and potential fat-soluble vitamin malabsorption.
56:44
SPEAKER_01: It essentially forces behavioral compliance by punishing the patient physically
56:48
SPEAKER_01: if they eat a high-fat meal.
56:50
SPEAKER_01: What about the combination drugs that act centrally on the brain, affecting appetite and reward?
56:55
SPEAKER_00: Yes, these target the hypothalamic pathways.
56:58
SPEAKER_00: Phenterminatopyramate,
56:59
SPEAKER_00: marketed as QCA,
57:01
SPEAKER_00: combines a stimulant to reduce appetite with an anticonvulsant
57:04
SPEAKER_00: that promotes satiety.
57:06
SPEAKER_00: It yields a robust 9% to 10% weight loss.
57:09
SPEAKER_01: Are there risks for psychiatric patients?
57:11
SPEAKER_00: It carries significant risks,
57:12
SPEAKER_00: paresthesias,
57:13
SPEAKER_00: dry mouth,
57:14
SPEAKER_00: cognitive dulling,
57:15
SPEAKER_00: and crucially for psychiatrists,
57:17
SPEAKER_00: potential exacerbation of mood and sleep disorders,
57:20
SPEAKER_00: and an elevated risk of suicidal ideation.
57:23
SPEAKER_00: Another option is naltrexenobupropion or Contra.
57:26
SPEAKER_01: How does that one work?
57:27
SPEAKER_00: This ingenious combination acts on both the adrenergic and dopaminergic receptors in
57:32
SPEAKER_00: the hypothalamus to reduce cravings and enhance satiety,
57:35
SPEAKER_00: yielding 5% to 10% weight loss.
57:37
SPEAKER_00: But psychiatrists must be highly aware of potential dangerous drug interactions,
57:41
SPEAKER_00: particularly with SSRIs and MAYs, as bupropion lowers the seizure threshold.
57:45
SPEAKER_01: And then we have the absolute revolution in obesity medicine,
57:48
SPEAKER_01: the newest class making global headlines and creating drug shortages everywhere.
57:52
SPEAKER_00: The GLP-1 receptor agonists,
57:54
SPEAKER_00: such as liraglutide, marketed as Saxenda, and the newer semaglutide formulations.
57:59
SPEAKER_00: These medications mimic the naturally occurring glucagon-like peptide-1 hormone.
58:03
SPEAKER_01: They work via a dual mechanism, correct?
58:05
SPEAKER_00: Yes.
58:05
SPEAKER_00: Peripherally,
58:06
SPEAKER_00: they significantly delay gastric emptying,
58:09
SPEAKER_00: keeping the stomach physically fuller for longer.
58:11
SPEAKER_00: Centrally,
58:12
SPEAKER_00: they cross the blood-brain barrier and strongly regulate areas of
58:15
SPEAKER_00: the hypothalamus involved in appetite, massively reducing hunger and cravings.
58:20
SPEAKER_01: The weight loss results are highly promising,
58:23
SPEAKER_01: frequently exceeding the efficacy of older medications.
58:26
SPEAKER_01: The risks include severe nausea, potential pancreatitis, and an increased resting heart rate.
58:31
SPEAKER_00: But the most vital overarching caveat across all
58:35
SPEAKER_00: of these pharmacological interventions is the lack of biological permanence.
58:38
SPEAKER_01: Meaning when you stop taking them, the weight comes back.
58:41
SPEAKER_00: The clinical trials are clear.
58:42
SPEAKER_00: When the medication is discontinued, the weight is almost universally and rapidly regained.
58:47
SPEAKER_00: The ancient biology reasserts itself the moment the chemical blockade is removed.
58:51
SPEAKER_01: Which leaves us with the most invasive but ultimately
58:53
SPEAKER_01: the most effective long-term treatment for severe refractory obesity,
58:58
SPEAKER_01: bariatric surgery.
59:00
SPEAKER_01: The indications here are strict.
59:02
SPEAKER_01: A BMI greater than 40 or a BMI greater than 35 with severe medical comorbidities.
59:07
SPEAKER_00: Bariatric surgery is not merely a cosmetic procedure.
59:11
SPEAKER_00: It fundamentally alters the gastrointestinal anatomy and the body's hormonal environment.
59:16
SPEAKER_00: The most common procedure performed today is the laparoscopic sleeve gastrectomy,
59:20
SPEAKER_00: or LSG, making up nearly 60% of all bariatric procedures.
59:24
SPEAKER_01: It's primarily a restrictive procedure, right?
59:27
SPEAKER_00: Yes.
59:27
SPEAKER_00: The surgeon permanently removes 70% to 80% of the stomach.
59:31
SPEAKER_00: This not only drastically restricts the sheer volume of food
59:34
SPEAKER_00: the patient can consume inducing early mechanical satiety but critically it removes
59:39
SPEAKER_00: the gastric fundus.
59:41
SPEAKER_01: Which is the primary site of production for ghrelin, the body's major hunger hormone.
59:45
SPEAKER_01: So the patient physically cannot eat as much, and chemically, they feel less hungry.
59:49
SPEAKER_00: Exactly.
59:50
SPEAKER_00: The other major procedure,
59:51
SPEAKER_00: the Roux-en-Way gastric bypass,
59:53
SPEAKER_00: combines severe restriction with profound malabsorption by surgically bypassing
59:57
SPEAKER_00: a large segment of the small intestine.
1:00:00
SPEAKER_00: These procedures result in massive,
1:00:02
SPEAKER_00: life-altering weight loss, often 40% to 80% of excess body weight.
1:00:06
SPEAKER_01: And they frequently cause the complete rapid resolution
1:00:10
SPEAKER_01: of life-threatening comorbidities like type 2 diabetes and hypertension,
1:00:13
SPEAKER_01: sometimes within days of the surgery.
1:00:15
SPEAKER_01: But a psychiatrist's or psychologist's role here is absolutely mandatory.
1:00:20
SPEAKER_01: A surgeon will not operate without psychiatric clearance.
1:00:23
SPEAKER_00: Absolutely.
1:00:24
SPEAKER_00: Rigorous pre-surgical psychological evaluations are the standard of care globally.
1:00:28
SPEAKER_00: We must comprehensively assess the patient's motivation
1:00:31
SPEAKER_00: and Their realistic understanding of the massive lifelong dietary
1:00:35
SPEAKER_00: and lifestyle changes required post-surgery
1:00:38
SPEAKER_00: and their baseline psychological stability.
1:00:40
SPEAKER_01: Because the prevalence of psychopathology in this population is immense.
1:00:43
SPEAKER_01: Up to 68% of bariatric surgical candidates present with a lifetime incidence
1:00:48
SPEAKER_01: of Axis Psychiatric Disorders.
1:00:50
SPEAKER_01: What are the absolute hard contraindications where you,
1:00:54
SPEAKER_01: as the consulting psychiatrist, must tell the surgeon, no, you cannot operate?
1:00:57
SPEAKER_00: The hard contraindications include active,
1:01:00
SPEAKER_00: untreated bulimia nervosa,
1:01:01
SPEAKER_00: severe and unstable psychosis,
1:01:04
SPEAKER_00: severe treatment refractory depression,
1:01:06
SPEAKER_00: Any active suicidal ideation or recent attempts,
1:01:09
SPEAKER_00: and crucially, any active untreated substance abuse disorder.
1:01:12
SPEAKER_01: And our role extends far beyond the pre-op evaluation.
1:01:16
SPEAKER_01: Post-surgery,
1:01:18
SPEAKER_01: psychiatrists must vigilantly monitor for a phenomenon known as symptom substitution
1:01:22
SPEAKER_01: or transfer addiction.
1:01:24
SPEAKER_00: This is critical.
1:01:25
SPEAKER_00: If a patient historically utilized massive quantities of food to cope
1:01:29
SPEAKER_00: with severe childhood trauma,
1:01:31
SPEAKER_00: and the surgeon physically removes their physiological ability
1:01:33
SPEAKER_00: to consume large quantities of food,
1:01:35
SPEAKER_00: that underlying unresolved trauma and anxiety do not magically vanish from
1:01:40
SPEAKER_00: the psyche.
1:01:40
SPEAKER_01: The distress remains.
1:01:41
SPEAKER_00: Exactly.
1:01:42
SPEAKER_00: Deprived of their primary coping mechanism,
1:01:44
SPEAKER_00: The psychological system always finds a way to express the distress.
1:01:47
SPEAKER_00: You cannot operate on the mind with a scalpel.
1:02:13
SPEAKER_01: Which brings us to the grand synthesis of this entire deep dive.
1:02:17
SPEAKER_01: Obesity is not a simple lack of discipline.
1:02:20
SPEAKER_01: It is not a character flaw.
1:02:22
SPEAKER_01: It is the highly visible physical outcome of an incredibly complex, entirely invisible system.
1:02:29
SPEAKER_00: It requires a holistic,
1:02:30
SPEAKER_00: deeply empathetic,
1:02:31
SPEAKER_00: and rigorously biologically informed approach from all psychiatric
1:02:35
SPEAKER_00: and medical professionals.
1:02:36
SPEAKER_00: You have to look at the thrifty genes,
1:02:38
SPEAKER_00: the suffocating adipocytes,
1:02:40
SPEAKER_00: the energy harvesting gut,
1:02:41
SPEAKER_00: the unresolved trauma,
1:02:42
SPEAKER_00: the toxic environment, and the iatrogenic impact of our own medications.
1:02:47
SPEAKER_01: It demands total clinical integration.
1:02:49
SPEAKER_01: You cannot treat the weight without treating the mind,
1:02:51
SPEAKER_01: and you cannot treat the mind without acknowledging the body.
1:02:53
SPEAKER_01: And that leads me to a final provocative thought.
1:02:55
SPEAKER_01: I want to leave you...
1:02:57
SPEAKER_01: I love this part.
1:03:16
SPEAKER_01: And if that is true,
1:03:17
SPEAKER_01: at what point does our primary clinical duty move from treating
1:03:21
SPEAKER_01: the broken individual patient sitting in our office to actively advocating,
1:03:23
SPEAKER_01: treating, and reforming the environment itself?
1:03:46
SPEAKER_00: A truly paradigm shifting question and one that correctly forces us to look far
1:03:51
SPEAKER_00: beyond the four walls of the clinic.
1:03:53
SPEAKER_00: Now, to reinforce the complex mental models we have built today,
1:03:55
SPEAKER_00: let us test your clinical reasoning
1:03:57
SPEAKER_00: with five single best answer questions drawn directly from the material.
1:04:01
SPEAKER_00: Listeners,
1:04:02
SPEAKER_00: I encourage you to pause the audio after I read the question and the options
1:04:05
SPEAKER_00: to formulate your own clinical rationale before I reveal the answer.
1:04:08
SPEAKER_00: Ready?
1:04:08
SPEAKER_01: Let's do it.
1:04:09
SPEAKER_00: Question one.
1:04:10
SPEAKER_00: Concept.
1:04:11
SPEAKER_00: A 32 year old patient presents to your clinic reporting
1:04:14
SPEAKER_00: that they frequently eat massive amounts of food very rapidly,
1:04:17
SPEAKER_00: often alone in their car.
1:04:19
SPEAKER_00: During these episodes,
1:04:20
SPEAKER_00: they report feeling immense guilt,
1:04:22
SPEAKER_00: deep shame and a complete terrifying loss of control.
1:04:26
SPEAKER_00: However,
1:04:27
SPEAKER_00: upon rigorous questioning,
1:04:28
SPEAKER_00: they confirmed they do not use laxatives,
1:04:31
SPEAKER_00: they do not induce vomiting,
1:04:32
SPEAKER_00: and they do not engage in compensatory fasting or excessive exercise following
1:04:36
SPEAKER_00: the episodes.
1:04:37
SPEAKER_00: Based strictly on the DSM-5 criteria, what is the most likely diagnosis?
1:04:42
SPEAKER_00: A, bulimia nervosa.
1:04:43
SPEAKER_00: B, binge eating disorder.
1:04:45
SPEAKER_00: C, night eating syndrome.
1:04:47
SPEAKER_00: D, unspecified feeding or eating disorder.
1:04:50
SPEAKER_01: Take a second to think about it.
1:04:52
SPEAKER_00: The correct answer is B, binge eating disorder.
1:04:54
SPEAKER_00: The absolute lack of recurrent compensatory purging behaviors,
1:04:58
SPEAKER_00: such as vomiting or laxative abuse,
1:05:00
SPEAKER_00: is the critical clinical differentiator that distinguishes binge eating disorder
1:05:03
SPEAKER_00: from bulimia nervosa.
1:05:05
SPEAKER_00: Night eating syndrome would require a distinct circadian delay in eating,
1:05:09
SPEAKER_00: such as waking from sleep.
1:05:10
SPEAKER_01: Right, the terrifying loss of control without the frantic purge.
1:05:12
SPEAKER_01: Let's move to question two, focusing on the neurobiology.
1:05:15
SPEAKER_00: Question two, mechanism.
1:05:18
SPEAKER_00: According to neurobiological research utilizing the Yale Food Addiction Scale,
1:05:22
SPEAKER_00: what specific mechanism is primarily responsible for driving
1:05:25
SPEAKER_00: the relentless escalating cycle
1:05:27
SPEAKER_00: of overeating highly palatable ultra-processed foods?
1:05:31
SPEAKER_00: A. Upregulation of serotonin receptors in the gut.
1:05:34
SPEAKER_00: B.
1:05:35
SPEAKER_00: Increased sensitivity to leptin in the hypothalamus.
1:05:37
SPEAKER_00: C. Downregulation of dopamine D2 receptors in the reward circuitry.
1:05:41
SPEAKER_00: D. Enhanced production of grulin by the gastric fundus.
1:05:45
SPEAKER_01: What's the mechanism here?
1:05:46
SPEAKER_00: The correct answer is C, the downregulation of dopamine D2 receptors.
1:05:50
SPEAKER_00: Recurrent intense exposure to hyperpalatable foods triggers massive dopamine release.
1:05:56
SPEAKER_00: To protect itself, the brain downregulates the receptors, leading to a blunted reward response.
1:06:00
SPEAKER_00: This requires the individual to consume increasingly larger amounts of the food
1:06:04
SPEAKER_00: to achieve the same baseline level of satisfaction or reward,
1:06:07
SPEAKER_00: perfectly mirroring the tolerance mechanism seen in severe substance use disorders.
1:06:11
SPEAKER_01: The exact same neural tracks as cocaine addiction.
1:06:13
SPEAKER_01: Let's look at question three, stepping back into the psychiatric dispensary.
1:06:16
SPEAKER_00: Question three, clinical reasoning.
1:06:19
SPEAKER_00: You are the admitting psychiatrist treating a 28-year-old male with
1:06:22
SPEAKER_00: a severe exacerbation of schizophrenia who requires
1:06:25
SPEAKER_00: a new antipsychotic medication regimen.
1:06:28
SPEAKER_00: However,
1:06:29
SPEAKER_00: upon reviewing his chart,
1:06:30
SPEAKER_00: you note he already has a BMI of 36,
1:06:33
SPEAKER_00: elevated fasting glucose, and documented metabolic syndrome.
1:06:37
SPEAKER_00: Which of the following medications is most likely
1:06:39
SPEAKER_00: to severely exacerbate his weight gain and metabolic dysfunction
1:06:42
SPEAKER_00: and therefore should generally be avoided as a first-line option
1:06:45
SPEAKER_00: if clinically possible?
1:06:52
SPEAKER_01: Which one is the worst offender?
1:06:54
SPEAKER_00: The correct answer is C, olanzapine.
1:06:57
SPEAKER_00: Along with clozapine,
1:06:58
SPEAKER_00: olanzapine possesses one of the highest,
1:07:00
SPEAKER_00: most aggressive weight gain profiles among all psychotropic medications,
1:07:03
SPEAKER_00: averaging an astonishing 2.3 kilograms of weight gain per month.
1:07:07
SPEAKER_00: It achieves this through potent antagonism of histamine and serotonin receptors,
1:07:12
SPEAKER_00: driving immense hyperphagia.
1:07:14
SPEAKER_00: Aripiprazole and Ziprocodone are considered far more wheat-neutral alternatives.
1:07:18
SPEAKER_01: Patching the roof but flooding the basement with histamine blockade.
1:07:22
SPEAKER_01: Let's tackle question four regarding the psychology of behavior change.
1:07:25
SPEAKER_00: Question four, concept.
1:07:27
SPEAKER_00: A patient in your weight management clinic acknowledges they desperately need
1:07:31
SPEAKER_00: to lose weight to manage their worsening type 2 diabetes.
1:07:34
SPEAKER_00: They proudly tell you they have recently purchased a gym membership
1:07:37
SPEAKER_00: and bought brand new running shoes,
1:07:39
SPEAKER_00: but they sheepishly admit they haven't actually gone to the gym
1:07:42
SPEAKER_00: or started exercising yet.
1:07:44
SPEAKER_00: According to Prochaska and DiClemente's transtheoretical model of change,
1:07:48
SPEAKER_00: which specific stage is this patient currently occupying?
1:07:52
SPEAKER_00: A, pre-contemplation.
1:07:54
SPEAKER_00: B, contemplation.
1:07:55
SPEAKER_00: C, preparation.
1:07:57
SPEAKER_00: D, action.
1:07:59
SPEAKER_01: Where are they on the spiral?
1:08:00
SPEAKER_00: The correct answer is C, the preparation stage.
1:08:03
SPEAKER_00: The patient is no longer stuck in the ambivalence of contemplation.
1:08:05
SPEAKER_00: They are actively intending to take measurable action within the immediate future
1:08:09
SPEAKER_00: and are taking small preliminary baby steps like buying the shoes and
1:08:12
SPEAKER_00: the membership.
1:08:13
SPEAKER_00: However,
1:08:14
SPEAKER_00: because overt,
1:08:15
SPEAKER_00: significant behavior modification has not yet commenced,
1:08:17
SPEAKER_00: they've not yet reached the action stage.
1:08:19
SPEAKER_01: They aren't in action until they actually sweat in those brand new shoes.
1:08:22
SPEAKER_01: And the final question, focusing on clinical interventions.
1:08:25
SPEAKER_00: Question five.
1:08:26
SPEAKER_00: Clinical reasoning.
1:08:28
SPEAKER_00: When prescribing rigorous behavioral weight loss strategies to a patient,
1:08:32
SPEAKER_00: what specific aspect of dietary self-monitoring should
1:08:35
SPEAKER_00: the clinician heavily emphasize as being the single strongest predictor
1:08:39
SPEAKER_00: of successful long-term weight maintenance?
1:08:42
SPEAKER_00: A.
1:08:43
SPEAKER_00: Think about what actually drives adherence.
1:09:01
SPEAKER_00: The correct answer is C, the frequency and consistency of the logging.
1:09:04
SPEAKER_00: Extensive research demonstrates that the habitual,
1:09:06
SPEAKER_00: consistent behavioral tracking of meals matters vastly more
1:09:09
SPEAKER_00: for long-term weight maintenance than the obsessive,
1:09:12
SPEAKER_00: granular precision regarding exact weights or macronutrients,
1:09:14
SPEAKER_00: which often leads to psychological burnout.
1:09:16
SPEAKER_01: Phenomenal.
1:09:17
SPEAKER_01: We have comprehensively mapped the great energy exchange,
1:09:20
SPEAKER_01: traveling from the ancient thrifty genes to the modern surgical suites.
1:09:24
SPEAKER_01: Thank you for joining us on this deep dive.
1:09:27
SPEAKER_01: Remember, this discussion is designed as a companion tool.
1:09:30
SPEAKER_01: We highly encourage you to direct yourself back to Chapter 27.4 of Kaplan
1:09:35
SPEAKER_01: and Cydox's Comprehensive Textbook of Psychiatry to rigorously review
1:09:39
SPEAKER_01: the specific nuances,
1:09:41
SPEAKER_01: the exhaustive medication tables,
1:09:43
SPEAKER_01: and the diagnostic criteria for your own clinical practice.
1:09:46
SPEAKER_00: True psychiatric knowledge is most valuable when it is continuously examined,
1:09:51
SPEAKER_00: deeply understood,
1:09:52
SPEAKER_00: and compassionately applied to the complex,
1:09:54
SPEAKER_00: struggling human beings sitting in front of you.
1:09:56
SPEAKER_01: Keep questioning the simplistic equations,
1:09:58
SPEAKER_01: keep looking for the hidden biological gears,
1:10:00
SPEAKER_01: and keep striving to understand the entire interconnected system.
1:10:04
SPEAKER_01: Thank you for your time and farewell on your journey as a lifelong learner in
1:10:08
SPEAKER_01: the ever-evolving field of psychiatry.